0000788920 2024-07-01 2025-06-30 0000788920 2024-12-31 0000788920 2025-09-03 0000788920 2025-06-30 0000788920 2024-06-30 0000788920 2023-07-01 2024-06-30 0000788920 us-gaap:CommonStockMember 2023-06-30 0000788920 us-gaap:RetainedEarningsMember 2023-06-30 0000788920 2023-06-30 0000788920 us-gaap:CommonStockMember 2024-06-30 0000788920 us-gaap:RetainedEarningsMember 2024-06-30 0000788920 us-gaap:CommonStockMember 2023-07-01 2024-06-30 0000788920 us-gaap:RetainedEarningsMember 2023-07-01 2024-06-30 0000788920 us-gaap:CommonStockMember 2024-07-01 2025-06-30 0000788920 us-gaap:RetainedEarningsMember 2024-07-01 2025-06-30 0000788920 us-gaap:CommonStockMember 2025-06-30 0000788920 us-gaap:RetainedEarningsMember 2025-06-30 0000788920 us-gaap:BuildingMember 2024-07-01 2025-06-30 0000788920 us-gaap:EquipmentMember 2024-07-01 2025-06-30 0000788920 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2024-07-01 2025-06-30 0000788920 us-gaap:FairValueInputsLevel1Member 2025-06-30 0000788920 us-gaap:FairValueInputsLevel2Member 2025-06-30 0000788920 us-gaap:FairValueInputsLevel3Member 2025-06-30 0000788920 us-gaap:FairValueInputsLevel1Member 2024-06-30 0000788920 us-gaap:FairValueInputsLevel2Member 2024-06-30 0000788920 us-gaap:FairValueInputsLevel3Member 2024-06-30 0000788920 2023-10-01 2023-10-06 0000788920 us-gaap:LandMember 2025-06-30 0000788920 us-gaap:LandMember 2024-06-30 0000788920 us-gaap:BuildingMember 2025-06-30 0000788920 us-gaap:BuildingMember 2024-06-30 0000788920 pdex:FranklinMember 2020-11-05 2020-11-06 0000788920 pdex:FranklinMember 2024-07-01 2025-06-30 0000788920 pdex:FranklinMember 2023-07-01 2024-06-30 0000788920 pdex:FranklinMember 2025-06-30 0000788920 us-gaap:FurnitureAndFixturesMember 2025-06-30 0000788920 us-gaap:FurnitureAndFixturesMember 2024-06-30 0000788920 us-gaap:MachineryAndEquipmentMember 2025-06-30 0000788920 us-gaap:MachineryAndEquipmentMember 2024-06-30 0000788920 us-gaap:AutomobilesMember 2025-06-30 0000788920 us-gaap:AutomobilesMember 2024-06-30 0000788920 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2025-06-30 0000788920 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2024-06-30 0000788920 pdex:MinnesotaBankAndTrustMember pdex:TermLoanCMember 2024-07-31 0000788920 pdex:MinnesotaBankAndTrustMember pdex:TermLoanCMember 2025-04-08 0000788920 pdex:MinnesotaBankAndTrustMember pdex:TermLoanAandBMember 2025-06-30 0000788920 pdex:MinnesotaBankAndTrustMember pdex:PropertyLoanMember 2025-06-30 0000788920 pdex:MinnesotaBankAndTrustMember pdex:TermLoanCMember 2025-06-30 0000788920 pdex:MinnesotaBankAndTrustMember pdex:AmendedRevolvingLoanMember 2025-06-30 0000788920 pdex:MinnesotaBankAndTrustMember pdex:TermLoanAandBMember 2024-07-01 2025-06-30 0000788920 pdex:MinnesotaBankAndTrustMember pdex:TermLoanCMember 2024-07-01 2025-06-30 0000788920 pdex:MinnesotaBankAndTrustMember pdex:PropertyLoanMember 2024-07-01 2025-06-30 0000788920 pdex:MinnesotaBankAndTrustMember pdex:AmendedRevolvingLoanMember 2024-07-01 2025-06-30 0000788920 pdex:MinnesotaBankAndTrustMember 2024-07-01 2025-06-30 0000788920 pdex:TermLoanAMember 2025-06-30 0000788920 pdex:TermLoanAMember 2024-06-30 0000788920 pdex:TermLoanBMember 2025-06-30 0000788920 pdex:TermLoanBMember 2024-06-30 0000788920 pdex:TermLoanCMember 2025-06-30 0000788920 pdex:TermLoanCMember 2024-06-30 0000788920 pdex:PropertyLoanMember 2025-06-30 0000788920 pdex:PropertyLoanMember 2024-06-30 0000788920 pdex:AmendedRevolvingLoanMember 2025-06-30 0000788920 pdex:AmendedRevolvingLoanMember 2024-06-30 0000788920 pdex:RetirementSavings401kPlanMember 2024-07-01 2025-06-30 0000788920 pdex:RetirementSavings401kPlanMember 2023-07-01 2024-06-30 0000788920 pdex:EquityIncentivePlan2016Member 2016-03-31 0000788920 us-gaap:PerformanceSharesMember pdex:EquityIncentivePlan2016Member 2024-07-01 2025-06-30 0000788920 pdex:NonQualifiedStockOptionsMember pdex:EquityIncentivePlan2016Member 2024-07-01 2025-06-30 0000788920 pdex:RestrictedSharesMember pdex:EquityIncentivePlan2016Member 2024-07-01 2025-06-30 0000788920 pdex:PreviouslyForfeitedAwardsMember 2023-10-01 2023-10-31 0000788920 us-gaap:PerformanceSharesMember 2024-07-01 2025-06-30 0000788920 us-gaap:PerformanceSharesMember 2023-07-01 2024-06-30 0000788920 us-gaap:PerformanceSharesMember 2024-06-29 2024-07-02 0000788920 pdex:DirectorsAndCertainEmployeesMember pdex:NonQualifiedStockOptionsMember pdex:EquityIncentivePlan2016Member 2020-12-01 2020-12-31 0000788920 pdex:DirectorsAndCertainEmployeesMember pdex:NonQualifiedStockOptionsMember pdex:EquityIncentivePlan2016Member 2021-02-27 2021-02-28 0000788920 pdex:DirectorsAndCertainEmployeesMember pdex:NonQualifiedStockOptionsMember pdex:EquityIncentivePlan2016Member 2020-07-01 2021-06-30 0000788920 pdex:DirectorsAndCertainEmployeesMember pdex:NonQualifiedStockOptionsMember pdex:EquityIncentivePlan2016Member 2021-12-01 2021-12-31 0000788920 pdex:DirectorsAndCertainEmployeesMember pdex:RestrictedSharesMember pdex:EquityIncentivePlan2016Member 2024-11-01 2024-11-30 0000788920 pdex:DirectorsAndCertainEmployeesMember pdex:RestrictedSharesMember pdex:EquityIncentivePlan2016Member 2024-07-01 2025-06-30 0000788920 pdex:DirectorsAndCertainEmployeesMember pdex:RestrictedSharesMember pdex:EquityIncentivePlan2016Member 2025-06-30 0000788920 pdex:DirectorsAndCertainEmployeesMember pdex:RestrictedSharesMember pdex:EquityIncentivePlan2016Member 2025-01-01 2025-06-30 0000788920 pdex:EmployeeStockPurchasePlanMember 2014-09-01 2014-09-30 0000788920 pdex:EmployeeStockPurchasePlanMember 2014-09-30 0000788920 pdex:EmployeeStockPurchasePlanMember 2024-07-01 2025-06-30 0000788920 pdex:EmployeeStockPurchasePlanMember 2023-07-01 2024-06-30 0000788920 us-gaap:PerformanceSharesMember 2024-06-30 0000788920 us-gaap:PerformanceSharesMember 2023-06-30 0000788920 us-gaap:PerformanceSharesMember 2025-06-30 0000788920 pdex:NonQualifiedStockOptionMember 2024-06-30 0000788920 pdex:NonQualifiedStockOptionMember 2023-06-30 0000788920 pdex:NonQualifiedStockOptionMember 2024-07-01 2025-06-30 0000788920 pdex:NonQualifiedStockOptionMember 2023-07-01 2024-06-30 0000788920 pdex:NonQualifiedStockOptionMember 2025-06-30 0000788920 pdex:CustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:CustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Customer1Member us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Customer1Member us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Customer2Member us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Customer2Member us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:TotalCustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:TotalCustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-06-30 0000788920 pdex:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-06-30 0000788920 pdex:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Customer1Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-06-30 0000788920 pdex:Customer1Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Customer1Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-06-30 0000788920 pdex:Customer1Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Customer2Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-06-30 0000788920 pdex:Customer2Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Customer2Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-06-30 0000788920 pdex:Customer2Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:TotalCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-06-30 0000788920 pdex:TotalCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:TotalCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-06-30 0000788920 pdex:TotalCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:SupplierMember pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:SupplierMember pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:SupplierMember pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:SupplierMember pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Supplier1Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:Supplier1Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Supplier1Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:Supplier1Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Supplier2Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:Supplier2Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Supplier2Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:Supplier2Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Supplier3Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:Supplier3Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Supplier3Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:Supplier3Member pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:TotalSupplierMember pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:TotalSupplierMember pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:TotalSupplierMember pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:TotalSupplierMember pdex:InventoryPurchasesMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:SupplierMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:SupplierMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:SupplierMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:SupplierMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Supplier1Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:Supplier1Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Supplier1Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:Supplier1Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Supplier2Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:Supplier2Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Supplier2Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:Supplier2Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:Supplier3Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:Supplier3Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:Supplier3Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:Supplier3Member us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:TotalSupplierMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2025-06-30 0000788920 pdex:TotalSupplierMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-07-01 2025-06-30 0000788920 pdex:TotalSupplierMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2024-06-30 0000788920 pdex:TotalSupplierMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-07-01 2024-06-30 0000788920 pdex:ShareRepurchaseProgramMember pdex:Tenb51PlanMember 2024-07-01 2025-06-30 0000788920 pdex:ShareRepurchaseProgramMember pdex:Tenb51PlanMember 2023-07-01 2024-06-30 0000788920 pdex:ShareRepurchaseProgramMember pdex:Tenb51PlanMember pdex:CumulativeBasisMember 2019-12-30 2019-12-31 0000788920 2025-04-01 2025-06-30 iso4217:USD shares iso4217:USD shares pure false 2025 FY 0000788920 10-K true 2025-06-30 --06-30 false 000-14942 PRO-DEX, INC. CO 2361 McGaw Avenue Irvine CA 84-1261240 92614 949 769-3200 Common Stock, no par value PDEX NASDAQ No No Yes Yes Non-accelerated Filer true false false false false 79900000 3261979 <span style="font-size: 10pt">Part III of this report incorporates by reference certain information from the registrant’s definitive proxy statement (the “Proxy Statement”) for its 2025 Annual Meeting of Shareholders. The Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</span> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240701__20250630_zZw9QAl33uzg">We have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_901_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240701__20250630_zwXsi0qyq131">implemented</span> and maintain various information security processes in accordance with our business designed to identify, assess, manage and protect against material risks from cybersecurity threats to our critical computer networks, communication systems, hardware and software, and our critical data, including intellectual property and confidential information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Depending on the environment, we implement and maintain various technical, physical and organizational measures, processes, and policies designed to manage and mitigate material risks from cybersecurity threats to our information systems and data, including, for example, incident detection and response plans; disaster recovery and business continuity plans; maintaining network security and access controls; asset management; monitoring certain of our systems and network; cybersecurity insurance; and training our employees about certain cybersecurity risks and threats.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240701__20250630_zubpEsAvRjs6">We currently engage third party information technology partners to design and manage our information security processes and system.</span> Working with our outsourced security team, our Chief Financial Officer manages the risk assessment and mitigation process. We hired a business systems and information technology manager in fiscal 2025 to increase our in-house expertise in this area. As we grow, we plan to develop a more robust and detailed strategy for cybersecurity.</p> We have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_901_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240701__20250630_zwXsi0qyq131">implemented</span> and maintain various information security processes in accordance with our business designed to identify, assess, manage and protect against material risks from cybersecurity threats to our critical computer networks, communication systems, hardware and software, and our critical data, including intellectual property and confidential information. true true <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Governance</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_909_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240701__20250630_zhIpodt7nyP5">Cybersecurity risks are overseen by the full Board of Directors and the Audit Committee as part of their regular oversight.</span> <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240701__20250630_zWdJ4culovgk">Members of the Board and Audit Committee are encouraged to engage in ad hoc conversations with management on cybersecurity related updates to our risk management and strategy. Cybersecurity incidents are reported to the Chief Financial Officer to determine incident severity and response.</span> In an effort to deter and detect cyber threats, we also provide all employees with access to digital assets with an ongoing cybersecurity awareness training program, which further educates employees and covers timely and relevant topics, including phishing, password protection, asset use and mobile security.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Risks from cybersecurity threats</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbT_c20240701__20250630_zFS4OikXxN8d">To date, we have not identified any cybersecurity incidents or threats that have materially affected us, or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition.</span> <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240701__20250630_zJ69OO4hTuYe">However, like many companies in our industry, we face numerous and evolving cybersecurity threats that could adversely affect our business. For more information about the risks from cybersecurity threats that may materially affect us and how they may do so, see our risk factors under Part 1 Item 1A Risk Factors contained elsewhere in this report.</span></p> Cybersecurity risks are overseen by the full Board of Directors and the Audit Committee as part of their regular oversight. Members of the Board and Audit Committee are encouraged to engage in ad hoc conversations with management on cybersecurity related updates to our risk management and strategy. Cybersecurity incidents are reported to the Chief Financial Officer to determine incident severity and response. true However, like many companies in our industry, we face numerous and evolving cybersecurity threats that could adversely affect our business. For more information about the risks from cybersecurity threats that may materially affect us and how they may do so, see our risk factors under Part 1 Item 1A Risk Factors contained elsewhere in this report. 23 Baker Tilly US, LLP Irvine, California 419000 2631000 6740000 4217000 16433000 13887000 24000 262000 22213000 15269000 1056000 410000 345000 47295000 36611000 6061000 6155000 5153000 5024000 1050000 1473000 26000 54000 1415000 1555000 148000 1563000 44000 42000 61192000 52477000 4614000 4513000 3479000 3359000 186000 632000 202000 14000 6148000 4374000 14629000 12892000 685000 1182000 9246000 7536000 9931000 8718000 24560000 21610000 0 0 50000000 50000000 3261043 3261043 3363412 3363412 704000 3917000 35928000 26950000 36632000 30867000 61192000 52477000 66593000 53844000 47083000 39293000 19510000 14551000 344000 117000 4841000 4072000 3636000 3189000 8821000 7378000 10689000 7173000 82000 144000 1521000 -4125000 595000 829000 558000 1369000 -4539000 12058000 2634000 3080000 507000 8978000 2127000 2.73 0.61 2.67 0.60 3287844 3498807 3361207 3571207 3545309 6767000 24823000 31590000 2127000 2127000 3004 50000 50000 605000 605000 184901 3505000 3505000 3363412 3917000 26950000 30867000 8978000 8978000 1593 42000 42000 40000 14866 273000 273000 1052 33000 33000 555000 555000 130148 3504000 3504000 3261043 704000 35928000 36632000 8978000 2127000 1239000 1160000 1521000 -4125000 595000 -33000 -17000 -9000 -12000 555000 605000 140000 -1563000 2546000 3935000 -238000 -232000 6944000 -898000 67000 49000 179000 2436000 188000 14000 -1502000 179000 -1682000 6224000 1246000 983000 1907000 899000 1250000 -238000 -2233000 11528000 4841000 15003000 4000000 3504000 3505000 -305000 42000 50000 -292000 -4296000 -2212000 -305000 2631000 2936000 419000 2631000 818000 555000 3030000 1515000 1427000 334000 8000 34000 4457000 1891000 117000 <p id="xdx_807_eus-gaap--NatureOfOperations_zDWjQt7TBoEf" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">1.        <span id="xdx_82F_zPHsAw9kWhIi">DESCRIPTION OF BUSINESS</span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We specialize in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial markets. We have patented adaptive torque-limiting technology and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries; however, these motors comprise a de minimis portion of our business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In August 2020, we formed a wholly owned subsidiary, PDEX Franklin, LLC (“PDEX Franklin”), to hold title for an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”) that we acquired on November 6, 2020, in order to allow for the continued growth of our business. The consolidated financial statements include the accounts of the Company and PDEX Franklin and all significant inter-company accounts and transactions have been eliminated. This subsidiary has no separate operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zBgfijD7jRG6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.        <span id="xdx_829_zVbhbtLloZi2">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The summary of significant accounting policies presented below is designed to assist the reader in understanding our consolidated financial statements. Such consolidated financial statements and related notes are the representations of management, who is responsible for their integrity and objectivity. In the opinion of management, these accounting policies conform to accounting principles generally accepted in the United States of America (“U.S. GAAP”) in all material respects and have been consistently applied in preparing the accompanying consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_849_ecustom--RevenueRecognitionSaleOfServices_zXX4jwAZxL91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zMvQs2VOK3ck">Net Sales</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net sales consists of the sale of products and services, as well as shipping and handling billed to our customers and is net of volume rebates and discounts and excludes sales tax.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zdOMNEmmD4Th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Revenue Recognition</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue from product sales is recognized as promulgated by the Financial Accounting Standards Board (“FASB”) in Accounting Standards Update (“ASU”) 2014-09, <i>Revenue from Contracts with Customers </i>once our contract(s) with a customer and the performance obligations in the contract have been identified, and the transaction price has been allocated to the performance obligations and revenue is recorded when (or as) we satisfy each performance obligation, generally upon shipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Revenue from services, typically non-recurring engineering (“NRE”) services related to the design or customization of a medical device, is typically recognized over time. The customer funding for costs incurred for NRE services is deferred and subsequently recognized as revenue as under-lying products or services are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funding amount, are deferred as an asset and recognized as cost of sales when the under-lying products or services are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) on our consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">One of our customer contracts can give rise to variable consideration due to volume rebates. We estimate variable consideration at the most likely amount we will receive from this customer. Our estimates of variable consideration are based on an assessment of our anticipated performance and all information (historical, current, and forecasted) that is reasonably available to us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Returns of our product for credit are minimal; accordingly, we do not establish a reserve for product returns at the time of sale.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_841_eus-gaap--CostOfSalesPolicyTextBlock_zpdwvr74dkVd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_86D_z0zQQ0Oc0ANb">Cost of Sales</span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of sales consists primarily of the purchase price of goods and cost of services rendered including freight costs. Cost of sales also includes production labor and overhead costs for all of our manufacturing and assembly operations, which overhead includes all indirect labor and expenses associated with our inspection, warehousing, material planning and quality departments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_848_ecustom--EstimatedLossesOnProductDevelopmentServicesPolicyTextBlock_ztP8wC5XMK0a" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_86C_zka3ixdNJWY4">Estimated Losses on Product Development Services</span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Cost and revenue estimates related to the product development service portions of development and supply contracts are reviewed and updated quarterly. An expected loss on development service contracts is recognized immediately in cost of sales. Losses recorded in fiscal 2025 and 2024 related to these services totaled $<span id="xdx_90E_eus-gaap--ProfitLoss_c20240701__20250630_pp0p" title="Losses on product development services">155,000</span> and $<span id="xdx_908_eus-gaap--ProfitLoss_c20230701__20240630_pp0p" title="Losses on product development services">118,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Due to the complexity of many of the contracts we have undertaken, the cost estimation process requires significant judgment. It is based upon the knowledge and experience of our project managers, engineers, and finance professionals. Factors that are considered in estimating the cost of work to be completed and ultimate profitability of the fixed price product development portion of development and supply contracts include the nature and complexity of the work to be performed, availability and productivity of labor, the effect of change orders, the availability of materials, performance of subcontractors, and expected costs for specific regulatory approvals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84E_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zKaUAptn6nR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zJp0y9Uc3Nac">Warranties</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain of our products are sold with a warranty that provides for repairs or replacement of any defective parts for a period, generally one to two years, after the sale. At the time of the sale, we accrue an estimate of the cost of providing the warranty based on prior experience with such factors as return rates and repair costs, which factors are reviewed quarterly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The warranty accrual is based on historical costs of warranty repairs and expected future identifiable warranty expenses and is included in accrued expenses in the accompanying consolidated balance sheets. Warranty expenses are included in cost of sales in the accompanying consolidated statements of operations. Changes in estimates to previously established warranty accruals result from current period updates to assumptions regarding repair costs and warranty return rates and are included in current period warranty expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zBlTCqohWyo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zpYGl9TGRIOd">Cash and Cash Equivalents</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We consider all highly liquid investments with an original maturity of ninety days or less to be cash equivalents. At June 30, 2025 and 2024, cash equivalents consisted of investments in money market funds.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_zbUcEtk0pqre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_zdQ74y4jFr79">Accounts Receivable</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Trade receivables are stated at their original invoice amounts, less an allowance for doubtful portions of such accounts represented by expected credit losses. Management determines the allowance for credit losses based on facts and circumstances related to specific accounts and the age of accounts. As of June 30, 2025 and 2024 we have <span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_pp0d_do_c20250630_zPGrGSiacpYb" title="Allowance for doubtful accounts"><span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_pp0d_do_c20240630_zinu3SHlGOGl" title="Allowance for doubtful accounts">no</span></span> allowance for doubtful accounts and expect to fully collect our trade receivable balances. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously reserved are offset against the allowance when received.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84A_eus-gaap--LesseeLeasesPolicyTextBlock_zLvDnYAfENw7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zJP9WcWOuBIh">Leases</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b>Our operating lease consists solely of our corporate headquarters located in Irvine, California. We do not have any leases classified as financing leases. We classify arrangements meeting the definition of a lease as operating or financing leases, and leases are recorded on the consolidated balance sheets as both a right-of-use asset (“ROU”) and lease liability, calculated by discounting the fixed lease payments over the term of the lease term at the rate implicit in the lease or our incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense over the lease term. Operating lease assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Variable lease expenses are recorded when incurred. We exclude short-term leases having an initial term of 12 months or less as an accounting policy election, and instead recognize rent expense on a straight-line basis over the term of the lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We assess the impairment of ROU assets when an event or change in circumstance indicates that the carrying value of such ROU assets may not be recoverable. If an event or a change in circumstance indicates that the carrying value of an ROU asset may not be recoverable and the estimated fair value attributable to the ROU asset is less than its carrying value, an impairment loss equal to the excess of the ROU’s carrying value over its estimated fair value is recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--DeferredChargesPolicyTextBlock_zlcE9KlDxJM4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86B_zKvUUrh8ATh">Deferred Costs</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deferred costs reflect costs incurred related to NRE services under the terms of the related development and/or supply contracts. These costs get recorded to cost of sales in the period that the revenue is recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_848_eus-gaap--InventoryPolicyTextBlock_zR6XiVOT49ng" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zQURmSjJK0M">Inventories</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Cost includes materials, labor, and manufacturing overhead related to the purchase and production of inventories. Reductions to estimated market value are recorded and charged to cost of sales, when indicated based on a formula that compares on-hand quantities to both historical usage and estimated demand as of the measurement date. On an ongoing basis, we evaluate inventory for obsolescence and slow-moving items. This evaluation includes analysis of historical sales and usage, existing demand, as well as specific factors known to management. As of June 30, 2025 and 2024, there was approximately $<span id="xdx_903_eus-gaap--OtherInventoryInTransit_c20250630_pp0p" title="Inventory in-transit">87,000</span> and $<span id="xdx_902_eus-gaap--OtherInventoryInTransit_c20240630_pp0p" title="Inventory in-transit">275,000</span>, respectively, of inventory in-transit from suppliers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_843_eus-gaap--InvestmentPolicyTextBlock_zlhzz18Mr0F2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zYwvfn7rXKwd">Investments</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investments at June 30, 2025 and 2024, consist of marketable equity securities of publicly held companies. The investments were made to realize a reasonable return, although there is no assurance that positive returns will be realized. Investments are marked to market at each measurement date, with unrealized gains and losses presented separately within other income and expense on the consolidated income statement. All of our investments consist of common stocks of public companies that are either thinly traded or we hold a significant (in excess of 5%) interest in. These investments were subject to a valuation analysis as of June 30, 2025 and 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zrNYN9BfTJE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zx0EBJcj5lV9">Long-lived Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We review the recoverability of long-lived assets, consisting of the land and building that we own, equipment, and improvements, including leasehold improvements, when events or changes in circumstances occur that indicate carrying values may not be recoverable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our building, equipment and improvements are recorded at historical cost and depreciation is provided using the straight-line method over the following periods:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--ScheduleOfBuildingEquipmentAndImprovementsTableTextBlock_zclo46SGlVY6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: top"> <td style="width: 36%"> <span id="xdx_8B7_z7BtdGtQV4Q3" style="display: none">Schedule of building, equipment and improvements</span></td> <td style="width: 64%"> </td></tr> <tr style="vertical-align: top"> <td>Building</td> <td><span id="xdx_900_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember" title="Estimated useful lives">Thirty years</span></td></tr> <tr style="vertical-align: top"> <td>Equipment</td> <td><span id="xdx_906_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember" title="Estimated useful lives">Three to ten years</span></td></tr> <tr style="vertical-align: top"> <td>Improvements</td> <td><span id="xdx_90F_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdsAndLeaseholdImprovementsMember" title="Estimated useful lives">Shorter of the remaining life of the underlying building, lease term, or the asset’s estimated useful life</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zALKnlxytCv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86B_zz2cU9YIEzPh">Intangibles</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt/11.3pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Intangibles consist </span>of <span style="letter-spacing: 0pt">legal fees incurred </span>in <span style="letter-spacing: 0pt">connection with patent applications. Our patent costs are being amortized over a period of four to seven years. The expense associated with the amortization of the patent costs is recognized in research and development costs.</span></p> <p style="font: 10pt/11.3pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt/11.3pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zqGEKXjLMbI4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zjKY065o66H1">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities along with net operating losses and tax credit carryovers. Net deferred tax assets or liabilities at both June 30, 2025 and 2024 consisted primarily of basis differences related to unrealized gain/loss related to investments, stock-based compensation, fixed assets, accrued expenses, and inventories. Our deferred tax assets also includes capitalization of our research expenditures as prescribed by the Tax Cuts and Jobs Act. While the One Big Beautiful Bill Act of 2025 (“OBBBA”) was enacted on July 4, 2025, we are continuing to evaluate the impact of OBBBA on our income tax provision and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant management judgment is required in determining the provision for income taxes, the recoverability of deferred tax assets, and the extinguishment of deferred tax liabilities. Such determination is based on historical taxable income, with consideration given to estimates of future taxable income and the periods over which deferred tax assets will be recoverable and deferred tax liabilities will be extinguished. We record a valuation allowance against deferred tax assets to reduce the net carrying value to an amount that we believe is more likely than not to be realized. When we establish or reduce the valuation allowance against deferred tax assets, the provision for income taxes will increase or decrease, respectively, in the period such determination is made.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--IncomeTaxUncertaintiesPolicy_zjuIUjqBilMh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_861_zuhiRRItjl38">Uncertain Tax Positions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We record uncertain tax positions in accordance with Accounting Standards Codification (“ASC”) 740 on the basis of a two-step process whereby (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position, and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_848_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zDjBUVcKaXSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86E_zE5NXZ1eny3">Shipping and Handling</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payments from customers for shipping and handling are included in net sales<i>.</i> Shipping expenses, consisting primarily of payments made to freight companies, are included in cost of sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zMejzX9L0CN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_863_zn8PJEWsf8Dl">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject us to credit risk consist principally of cash, cash equivalents, and trade receivables. We place our cash and cash equivalents with major financial institutions. At June 30, 2025 and 2024, and throughout the fiscal years then ended, we had deposits in excess of federally insured limits. Credit sales are made to medical device distributors, original equipment manufacturers, and resellers, and sales to such customers account for a substantial portion of our trade receivables. While such receivables are not collateralized, we evaluate their collectability based on several factors including customers’ payment histories.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84C_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zaFLEIJxmAQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86B_zmkBieyeimsl">Segment Reporting</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have identified one business segment which management also considers to be one reporting unit as our Chief Executive Officer (“CEO”) allocates resources, assesses performance, and manages our business as one segment. We have reached this conclusion because 99% of our fiscal 2025 business related to designing, manufacturing, and repairing medical devices. We primarily design, sell, and repair handheld medical devices and accessories. We provide medical devices, NRE and proto-type services, as well as repairs to all our customers and we utilize one machine shop and purchasing team to procure and manufacture all the products that we sell.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company’s chief operating decision maker (“CODM”) is our CEO who reviews and evaluates consolidated operating income for purposes of assessing performance, making operating decisions, allocating resources and planning and forecasting for future periods. As our operations are managed at the consolidated level, there are no differences between the measurement of the reportable segment’s profit or loss and our consolidated statements of operations. Further, there are no differences between i) segment revenues and expenses included in the measurement of the reportable segment’s profit or loss and used by the CODM to manage operations and ii) those disclosed elsewhere in the consolidated financial statements. Segment asset measures are not used as a basis for the CODM to evaluate the performance of or to allocate resources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zkBXYtCA4Tp9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_869_zoV23fNOrRS4">Compensation Plans</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">We recognize compensation expense for the share-based awards that vest subject to market conditions under ASC 718, <i>Compensation-Stock Compensation </i>by estimating their fair value using a Monte Carlo simulation. The fair value using a Monte Carlo simulation model is affected by assumptions regarding a number of complex judgments including expected stock price volatility, risk free interest rates, and the forecasted future value and trading volume of our stock. The awards are considered granted for accounting purposes on the date the awards were approved by the Compensation Committee of our Board of Directors and we recognize compensation expense, based on the estimated fair value of the award, on a straight-line basis over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"> </p> <p id="xdx_841_eus-gaap--UseOfEstimates_zJufux5Q3IIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b><span id="xdx_867_z82LwfkVxlLj">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operations are affected by numerous factors including market acceptance of our products, supply chain disruptions, changes in technologies, and new laws, government regulations, and policies. We cannot predict what impact, if any, the occurrence of these or other events might have on our operations. Significant estimates and assumptions made by management include, but are not limited to, revenue recognition, share-based compensation, the allowance for credit losses, accrued warranty expense, investments, inventory valuation, the carrying value of long-lived assets, and the recoverability/extinguishment of deferred income tax assets and liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zw3dZ2X9pHN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86B_zNXlrSBX0WVh">Basic and Diluted Per Share Information</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Basic per share amounts are computed on the basis of the weighted-average number of common shares outstanding during each period presented. Diluted per share amounts assume the issuance of all potential common stock equivalents, consisting of outstanding stock options and performance awards as discussed in Note 11, unless the effect of such exercise is to increase income, or decrease loss, per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zoQfgHX9Y1Oi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zXWpEEMeIJsl">Fair Value Measurements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Fair value is measured based on the prices that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Cash and cash equivalents: </i>The carrying value of cash and cash equivalents is considered to be representative of their fair values based on the short-term nature of these instruments. As such, cash and cash equivalents are classified within Level 1 of the valuation hierarchy.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Investments: </i>Investments consist of marketable equity securities of publicly held companies. Due to either the thinly traded nature of these stocks or our significant ownership percentage, in excess of 5% of shares outstanding, all of our investments are classified within Level 2 of the valuation hierarchy as of June 30, 2025 and 2024. The fair value of all of our investments at June 30, 2025 and 2024 was based upon a valuation analysis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although the methods above may produce a fair value calculation that may not be indicative of the net realizable value or reflective of future fair values, we believe our valuation methods are appropriate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zqiCCTOqO60l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zJ8xgXS2r9Xj">Advertising</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Advertising costs are charged to selling or general and administrative expense as incurred and amounted to $<span id="xdx_90C_eus-gaap--AdvertisingExpense_c20240701__20250630_pp0p" title="Advertising expense">78,000</span> and $<span id="xdx_90E_eus-gaap--AdvertisingExpense_c20230701__20240630_pp0p" title="Advertising expense">14,000</span> for the fiscal years ended June 30, 2025 and 2024, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_843_ecustom--ReclassificationsPolicyTextBlock_zPmTocxYP5ai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_z4nuCHDnhY26">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 31.5pt"> Certain prior year amounts have been reclassified to conform to the current year presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z3cE88Mmql53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_862_zzEtYjbYm61f">Recently Adopted Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">In December 2023, the FASB issued ASU No. 2023-09, <i>Income Taxes: Improvements to Income Tas Disclosures (Topic 740)</i>. ASU 2023-09 expands the existing rules on income tax disclosures. This update requires entities to disclose specific categories in the tax rate reconciliation, provide additional information for reconciling items that meet a quantitative threshold and disclose additional information about income taxes paid on an annual basis. </span>We adopted ASU 2023-09 effective July 1, 2024, and the adoption did not have a material impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">In November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting: Improvements to Reportable Segment Disclosures (Topic280) </i>which expands disclosure requirements to require entities to disclose significant segment expenses that are regularly provided to or easily computed from information regularly provided to the chief operating decision maker. This update also requires all annual disclosures currently required by Topic 280 to be disclosed in interim periods. </span>We adopted ASU 2023-07 effective June 30, 2025, and the adoption did not have a material impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_843_ecustom--RecentlyIssuedAndNotYetAdoptedAccountingPronouncementsPolicyTextBlock_zBPEN8tvkaE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86A_zJDisBzEKcC9">Recently Issued and Not Yet Adopted Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, <i>Disaggregation of Income Statement Expenses</i>. The ASU’s purpose is to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, selling, general and administrative, and research and development). This ASU is effective for fiscal years beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. We are currently evaluating these new expanded disclosure requirements, but this standard will not impact our results of operations or financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_849_ecustom--RevenueRecognitionSaleOfServices_zXX4jwAZxL91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zMvQs2VOK3ck">Net Sales</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net sales consists of the sale of products and services, as well as shipping and handling billed to our customers and is net of volume rebates and discounts and excludes sales tax.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zdOMNEmmD4Th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Revenue Recognition</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue from product sales is recognized as promulgated by the Financial Accounting Standards Board (“FASB”) in Accounting Standards Update (“ASU”) 2014-09, <i>Revenue from Contracts with Customers </i>once our contract(s) with a customer and the performance obligations in the contract have been identified, and the transaction price has been allocated to the performance obligations and revenue is recorded when (or as) we satisfy each performance obligation, generally upon shipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Revenue from services, typically non-recurring engineering (“NRE”) services related to the design or customization of a medical device, is typically recognized over time. The customer funding for costs incurred for NRE services is deferred and subsequently recognized as revenue as under-lying products or services are delivered to the customers. Additionally, expenses incurred, up to the customer agreed funding amount, are deferred as an asset and recognized as cost of sales when the under-lying products or services are delivered to the customer. The deferred customer funding and costs result in recognition of deferred costs (asset) and deferred revenue (liability) on our consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">One of our customer contracts can give rise to variable consideration due to volume rebates. We estimate variable consideration at the most likely amount we will receive from this customer. Our estimates of variable consideration are based on an assessment of our anticipated performance and all information (historical, current, and forecasted) that is reasonably available to us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Returns of our product for credit are minimal; accordingly, we do not establish a reserve for product returns at the time of sale.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_841_eus-gaap--CostOfSalesPolicyTextBlock_zpdwvr74dkVd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_86D_z0zQQ0Oc0ANb">Cost of Sales</span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of sales consists primarily of the purchase price of goods and cost of services rendered including freight costs. Cost of sales also includes production labor and overhead costs for all of our manufacturing and assembly operations, which overhead includes all indirect labor and expenses associated with our inspection, warehousing, material planning and quality departments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_848_ecustom--EstimatedLossesOnProductDevelopmentServicesPolicyTextBlock_ztP8wC5XMK0a" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_86C_zka3ixdNJWY4">Estimated Losses on Product Development Services</span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Cost and revenue estimates related to the product development service portions of development and supply contracts are reviewed and updated quarterly. An expected loss on development service contracts is recognized immediately in cost of sales. Losses recorded in fiscal 2025 and 2024 related to these services totaled $<span id="xdx_90E_eus-gaap--ProfitLoss_c20240701__20250630_pp0p" title="Losses on product development services">155,000</span> and $<span id="xdx_908_eus-gaap--ProfitLoss_c20230701__20240630_pp0p" title="Losses on product development services">118,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Due to the complexity of many of the contracts we have undertaken, the cost estimation process requires significant judgment. It is based upon the knowledge and experience of our project managers, engineers, and finance professionals. Factors that are considered in estimating the cost of work to be completed and ultimate profitability of the fixed price product development portion of development and supply contracts include the nature and complexity of the work to be performed, availability and productivity of labor, the effect of change orders, the availability of materials, performance of subcontractors, and expected costs for specific regulatory approvals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 155000 118000 <p id="xdx_84E_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zKaUAptn6nR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zJp0y9Uc3Nac">Warranties</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain of our products are sold with a warranty that provides for repairs or replacement of any defective parts for a period, generally one to two years, after the sale. At the time of the sale, we accrue an estimate of the cost of providing the warranty based on prior experience with such factors as return rates and repair costs, which factors are reviewed quarterly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The warranty accrual is based on historical costs of warranty repairs and expected future identifiable warranty expenses and is included in accrued expenses in the accompanying consolidated balance sheets. Warranty expenses are included in cost of sales in the accompanying consolidated statements of operations. Changes in estimates to previously established warranty accruals result from current period updates to assumptions regarding repair costs and warranty return rates and are included in current period warranty expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zBlTCqohWyo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zpYGl9TGRIOd">Cash and Cash Equivalents</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We consider all highly liquid investments with an original maturity of ninety days or less to be cash equivalents. At June 30, 2025 and 2024, cash equivalents consisted of investments in money market funds.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_zbUcEtk0pqre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_zdQ74y4jFr79">Accounts Receivable</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Trade receivables are stated at their original invoice amounts, less an allowance for doubtful portions of such accounts represented by expected credit losses. Management determines the allowance for credit losses based on facts and circumstances related to specific accounts and the age of accounts. As of June 30, 2025 and 2024 we have <span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_pp0d_do_c20250630_zPGrGSiacpYb" title="Allowance for doubtful accounts"><span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_pp0d_do_c20240630_zinu3SHlGOGl" title="Allowance for doubtful accounts">no</span></span> allowance for doubtful accounts and expect to fully collect our trade receivable balances. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously reserved are offset against the allowance when received.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 0 0 <p id="xdx_84A_eus-gaap--LesseeLeasesPolicyTextBlock_zLvDnYAfENw7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zJP9WcWOuBIh">Leases</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b>Our operating lease consists solely of our corporate headquarters located in Irvine, California. We do not have any leases classified as financing leases. We classify arrangements meeting the definition of a lease as operating or financing leases, and leases are recorded on the consolidated balance sheets as both a right-of-use asset (“ROU”) and lease liability, calculated by discounting the fixed lease payments over the term of the lease term at the rate implicit in the lease or our incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense over the lease term. Operating lease assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Variable lease expenses are recorded when incurred. We exclude short-term leases having an initial term of 12 months or less as an accounting policy election, and instead recognize rent expense on a straight-line basis over the term of the lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We assess the impairment of ROU assets when an event or change in circumstance indicates that the carrying value of such ROU assets may not be recoverable. If an event or a change in circumstance indicates that the carrying value of an ROU asset may not be recoverable and the estimated fair value attributable to the ROU asset is less than its carrying value, an impairment loss equal to the excess of the ROU’s carrying value over its estimated fair value is recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--DeferredChargesPolicyTextBlock_zlcE9KlDxJM4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86B_zKvUUrh8ATh">Deferred Costs</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deferred costs reflect costs incurred related to NRE services under the terms of the related development and/or supply contracts. These costs get recorded to cost of sales in the period that the revenue is recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_848_eus-gaap--InventoryPolicyTextBlock_zR6XiVOT49ng" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zQURmSjJK0M">Inventories</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Cost includes materials, labor, and manufacturing overhead related to the purchase and production of inventories. Reductions to estimated market value are recorded and charged to cost of sales, when indicated based on a formula that compares on-hand quantities to both historical usage and estimated demand as of the measurement date. On an ongoing basis, we evaluate inventory for obsolescence and slow-moving items. This evaluation includes analysis of historical sales and usage, existing demand, as well as specific factors known to management. As of June 30, 2025 and 2024, there was approximately $<span id="xdx_903_eus-gaap--OtherInventoryInTransit_c20250630_pp0p" title="Inventory in-transit">87,000</span> and $<span id="xdx_902_eus-gaap--OtherInventoryInTransit_c20240630_pp0p" title="Inventory in-transit">275,000</span>, respectively, of inventory in-transit from suppliers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 87000 275000 <p id="xdx_843_eus-gaap--InvestmentPolicyTextBlock_zlhzz18Mr0F2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zYwvfn7rXKwd">Investments</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investments at June 30, 2025 and 2024, consist of marketable equity securities of publicly held companies. The investments were made to realize a reasonable return, although there is no assurance that positive returns will be realized. Investments are marked to market at each measurement date, with unrealized gains and losses presented separately within other income and expense on the consolidated income statement. All of our investments consist of common stocks of public companies that are either thinly traded or we hold a significant (in excess of 5%) interest in. These investments were subject to a valuation analysis as of June 30, 2025 and 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zrNYN9BfTJE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zx0EBJcj5lV9">Long-lived Assets</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We review the recoverability of long-lived assets, consisting of the land and building that we own, equipment, and improvements, including leasehold improvements, when events or changes in circumstances occur that indicate carrying values may not be recoverable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our building, equipment and improvements are recorded at historical cost and depreciation is provided using the straight-line method over the following periods:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--ScheduleOfBuildingEquipmentAndImprovementsTableTextBlock_zclo46SGlVY6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: top"> <td style="width: 36%"> <span id="xdx_8B7_z7BtdGtQV4Q3" style="display: none">Schedule of building, equipment and improvements</span></td> <td style="width: 64%"> </td></tr> <tr style="vertical-align: top"> <td>Building</td> <td><span id="xdx_900_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember" title="Estimated useful lives">Thirty years</span></td></tr> <tr style="vertical-align: top"> <td>Equipment</td> <td><span id="xdx_906_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember" title="Estimated useful lives">Three to ten years</span></td></tr> <tr style="vertical-align: top"> <td>Improvements</td> <td><span id="xdx_90F_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdsAndLeaseholdImprovementsMember" title="Estimated useful lives">Shorter of the remaining life of the underlying building, lease term, or the asset’s estimated useful life</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--ScheduleOfBuildingEquipmentAndImprovementsTableTextBlock_zclo46SGlVY6" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: top"> <td style="width: 36%"> <span id="xdx_8B7_z7BtdGtQV4Q3" style="display: none">Schedule of building, equipment and improvements</span></td> <td style="width: 64%"> </td></tr> <tr style="vertical-align: top"> <td>Building</td> <td><span id="xdx_900_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember" title="Estimated useful lives">Thirty years</span></td></tr> <tr style="vertical-align: top"> <td>Equipment</td> <td><span id="xdx_906_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember" title="Estimated useful lives">Three to ten years</span></td></tr> <tr style="vertical-align: top"> <td>Improvements</td> <td><span id="xdx_90F_ecustom--PropertyPlantAndEquipmentEstimatedUsefulLive_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdsAndLeaseholdImprovementsMember" title="Estimated useful lives">Shorter of the remaining life of the underlying building, lease term, or the asset’s estimated useful life</span></td></tr> </table> Thirty years Three to ten years Shorter of the remaining life of the underlying building, lease term, or the asset’s estimated useful life <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zALKnlxytCv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86B_zz2cU9YIEzPh">Intangibles</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt/11.3pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Intangibles consist </span>of <span style="letter-spacing: 0pt">legal fees incurred </span>in <span style="letter-spacing: 0pt">connection with patent applications. Our patent costs are being amortized over a period of four to seven years. The expense associated with the amortization of the patent costs is recognized in research and development costs.</span></p> <p style="font: 10pt/11.3pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt/11.3pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zqGEKXjLMbI4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zjKY065o66H1">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities along with net operating losses and tax credit carryovers. Net deferred tax assets or liabilities at both June 30, 2025 and 2024 consisted primarily of basis differences related to unrealized gain/loss related to investments, stock-based compensation, fixed assets, accrued expenses, and inventories. Our deferred tax assets also includes capitalization of our research expenditures as prescribed by the Tax Cuts and Jobs Act. While the One Big Beautiful Bill Act of 2025 (“OBBBA”) was enacted on July 4, 2025, we are continuing to evaluate the impact of OBBBA on our income tax provision and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant management judgment is required in determining the provision for income taxes, the recoverability of deferred tax assets, and the extinguishment of deferred tax liabilities. Such determination is based on historical taxable income, with consideration given to estimates of future taxable income and the periods over which deferred tax assets will be recoverable and deferred tax liabilities will be extinguished. We record a valuation allowance against deferred tax assets to reduce the net carrying value to an amount that we believe is more likely than not to be realized. When we establish or reduce the valuation allowance against deferred tax assets, the provision for income taxes will increase or decrease, respectively, in the period such determination is made.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--IncomeTaxUncertaintiesPolicy_zjuIUjqBilMh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_861_zuhiRRItjl38">Uncertain Tax Positions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We record uncertain tax positions in accordance with Accounting Standards Codification (“ASC”) 740 on the basis of a two-step process whereby (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position, and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_848_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zDjBUVcKaXSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86E_zE5NXZ1eny3">Shipping and Handling</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payments from customers for shipping and handling are included in net sales<i>.</i> Shipping expenses, consisting primarily of payments made to freight companies, are included in cost of sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zMejzX9L0CN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_863_zn8PJEWsf8Dl">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject us to credit risk consist principally of cash, cash equivalents, and trade receivables. We place our cash and cash equivalents with major financial institutions. At June 30, 2025 and 2024, and throughout the fiscal years then ended, we had deposits in excess of federally insured limits. Credit sales are made to medical device distributors, original equipment manufacturers, and resellers, and sales to such customers account for a substantial portion of our trade receivables. While such receivables are not collateralized, we evaluate their collectability based on several factors including customers’ payment histories.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84C_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zaFLEIJxmAQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86B_zmkBieyeimsl">Segment Reporting</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have identified one business segment which management also considers to be one reporting unit as our Chief Executive Officer (“CEO”) allocates resources, assesses performance, and manages our business as one segment. We have reached this conclusion because 99% of our fiscal 2025 business related to designing, manufacturing, and repairing medical devices. We primarily design, sell, and repair handheld medical devices and accessories. We provide medical devices, NRE and proto-type services, as well as repairs to all our customers and we utilize one machine shop and purchasing team to procure and manufacture all the products that we sell.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company’s chief operating decision maker (“CODM”) is our CEO who reviews and evaluates consolidated operating income for purposes of assessing performance, making operating decisions, allocating resources and planning and forecasting for future periods. As our operations are managed at the consolidated level, there are no differences between the measurement of the reportable segment’s profit or loss and our consolidated statements of operations. Further, there are no differences between i) segment revenues and expenses included in the measurement of the reportable segment’s profit or loss and used by the CODM to manage operations and ii) those disclosed elsewhere in the consolidated financial statements. Segment asset measures are not used as a basis for the CODM to evaluate the performance of or to allocate resources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zkBXYtCA4Tp9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_869_zoV23fNOrRS4">Compensation Plans</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">We recognize compensation expense for the share-based awards that vest subject to market conditions under ASC 718, <i>Compensation-Stock Compensation </i>by estimating their fair value using a Monte Carlo simulation. The fair value using a Monte Carlo simulation model is affected by assumptions regarding a number of complex judgments including expected stock price volatility, risk free interest rates, and the forecasted future value and trading volume of our stock. The awards are considered granted for accounting purposes on the date the awards were approved by the Compensation Committee of our Board of Directors and we recognize compensation expense, based on the estimated fair value of the award, on a straight-line basis over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"> </p> <p id="xdx_841_eus-gaap--UseOfEstimates_zJufux5Q3IIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b><span id="xdx_867_z82LwfkVxlLj">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operations are affected by numerous factors including market acceptance of our products, supply chain disruptions, changes in technologies, and new laws, government regulations, and policies. We cannot predict what impact, if any, the occurrence of these or other events might have on our operations. Significant estimates and assumptions made by management include, but are not limited to, revenue recognition, share-based compensation, the allowance for credit losses, accrued warranty expense, investments, inventory valuation, the carrying value of long-lived assets, and the recoverability/extinguishment of deferred income tax assets and liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zw3dZ2X9pHN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86B_zNXlrSBX0WVh">Basic and Diluted Per Share Information</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Basic per share amounts are computed on the basis of the weighted-average number of common shares outstanding during each period presented. Diluted per share amounts assume the issuance of all potential common stock equivalents, consisting of outstanding stock options and performance awards as discussed in Note 11, unless the effect of such exercise is to increase income, or decrease loss, per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zoQfgHX9Y1Oi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zXWpEEMeIJsl">Fair Value Measurements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Fair value is measured based on the prices that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Cash and cash equivalents: </i>The carrying value of cash and cash equivalents is considered to be representative of their fair values based on the short-term nature of these instruments. As such, cash and cash equivalents are classified within Level 1 of the valuation hierarchy.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Investments: </i>Investments consist of marketable equity securities of publicly held companies. Due to either the thinly traded nature of these stocks or our significant ownership percentage, in excess of 5% of shares outstanding, all of our investments are classified within Level 2 of the valuation hierarchy as of June 30, 2025 and 2024. The fair value of all of our investments at June 30, 2025 and 2024 was based upon a valuation analysis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although the methods above may produce a fair value calculation that may not be indicative of the net realizable value or reflective of future fair values, we believe our valuation methods are appropriate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_843_eus-gaap--AdvertisingCostsPolicyTextBlock_zqiCCTOqO60l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zJ8xgXS2r9Xj">Advertising</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Advertising costs are charged to selling or general and administrative expense as incurred and amounted to $<span id="xdx_90C_eus-gaap--AdvertisingExpense_c20240701__20250630_pp0p" title="Advertising expense">78,000</span> and $<span id="xdx_90E_eus-gaap--AdvertisingExpense_c20230701__20240630_pp0p" title="Advertising expense">14,000</span> for the fiscal years ended June 30, 2025 and 2024, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 78000 14000 <p id="xdx_843_ecustom--ReclassificationsPolicyTextBlock_zPmTocxYP5ai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_z4nuCHDnhY26">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 31.5pt"> Certain prior year amounts have been reclassified to conform to the current year presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z3cE88Mmql53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_862_zzEtYjbYm61f">Recently Adopted Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">In December 2023, the FASB issued ASU No. 2023-09, <i>Income Taxes: Improvements to Income Tas Disclosures (Topic 740)</i>. ASU 2023-09 expands the existing rules on income tax disclosures. This update requires entities to disclose specific categories in the tax rate reconciliation, provide additional information for reconciling items that meet a quantitative threshold and disclose additional information about income taxes paid on an annual basis. </span>We adopted ASU 2023-09 effective July 1, 2024, and the adoption did not have a material impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">In November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting: Improvements to Reportable Segment Disclosures (Topic280) </i>which expands disclosure requirements to require entities to disclose significant segment expenses that are regularly provided to or easily computed from information regularly provided to the chief operating decision maker. This update also requires all annual disclosures currently required by Topic 280 to be disclosed in interim periods. </span>We adopted ASU 2023-07 effective June 30, 2025, and the adoption did not have a material impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_843_ecustom--RecentlyIssuedAndNotYetAdoptedAccountingPronouncementsPolicyTextBlock_zBPEN8tvkaE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86A_zJDisBzEKcC9">Recently Issued and Not Yet Adopted Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, <i>Disaggregation of Income Statement Expenses</i>. The ASU’s purpose is to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, selling, general and administrative, and research and development). This ASU is effective for fiscal years beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. We are currently evaluating these new expanded disclosure requirements, but this standard will not impact our results of operations or financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_807_ecustom--RevenueNetSalesDisclosureTextBlock_z0tqiNrvSpsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3.        <span id="xdx_828_zgKEuw64CHfl">NET SALES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents the disaggregation of net sales by revenue recognition model (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zvtDbtC2dX2i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NET SALES (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"><span id="xdx_8BF_zJorR6fjnl3k" style="display: none">Schedule of disaggregation of net sales</span> </span></td><td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_495_20240701__20250630_z4s2lx8SEPng" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td><td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_493_20230701__20240630_z3WoXphtyEk9" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year ended June 30,</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-size: 8pt">2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-size: 8pt">2024</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--RevenuesAbstract_i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Net Sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--OvertimeRevenueRecognition_pn3n3_maRzgbR_zT9cC1tl37o2" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Over-time revenue recognition </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">698</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">786</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--PointintimeRevenueRecognition_pn3n3_maRzgbR_zRpjig0NJ7bf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in">Point-in-time revenue recognition </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">65,895</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">53,058</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--Revenues_iT_pn3n3_mtRzgbR_zYbXOdpuevbb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in">Total net sales </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">66,593</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">53,844</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zmQnHRAhzgQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The timing of revenue recognition, billings, and cash collections results in billed accounts receivables, unbilled receivables (presented as deferred costs on our consolidated balance sheets) and customer advances and deposits (presented as deferred revenue on our consolidated balance sheets), where applicable. Amounts are generally billed as work progresses in accordance with agreed upon milestones. The over-time revenue recognition model consists of NRE and prototype services and typically relates to NRE services related to the evaluation, design or customization of a medical device and is typically recognized over time utilizing an input measure of progress based on costs incurred compared to the estimated total costs upon completion. During the fiscal years ended June 30, 2025 and 2024, we recorded $<span id="xdx_906_eus-gaap--DeferredRevenueNoncurrent_iI_pp0d_c20250630_zKqYgoh7gS2d" title="Deferred revenue">14,000</span> and $<span id="xdx_905_eus-gaap--DeferredRevenueNoncurrent_iI_pp0d_c20240630_zAziGzQyBoab" title="Deferred revenue">0</span>, respectively, of revenue that had been included in deferred revenue in the prior year. The revenue recognized from the contract liabilities consisted of satisfying our performance obligations during the normal course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following tables summarize our contract assets and liability balances (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_pn3n3_zmJ4dfyWJTyg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NET SALES (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"><span id="xdx_8BF_zTeCaJGhvhc1" style="display: none">Schedule of contract assets and liability</span> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Contract assets at beginning of year </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--ContractWithCustomerAssetNet_iS_pn3n3_c20240701__20250630_z4By6ApFXiZa" title="Contract assets at beginning of year">262</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90F_eus-gaap--ContractWithCustomerAssetNet_iS_pn3n3_c20230701__20240630_zHQOwnjSxG82" title="Contract assets at beginning of year">494</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Expenses incurred during the year </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--AccretionExpense_pn3n3_c20240701__20250630_zaTZuiTNk6E8" title="Expenses incurred during the year">228</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--AccretionExpense_pn3n3_c20230701__20240630_zeqqiupohLj9" title="Expenses incurred during the year">502</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Amounts reclassified to cost of sales </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--AmountsReclassifiedToCostOfSales_pn3n3_c20240701__20250630_z8Z5ytqUHWo3" title="Amounts reclassified to cost of sales">(460</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--AmountsReclassifiedToCostOfSales_pn3n3_c20230701__20240630_zir6p20u75Y8" title="Amounts reclassified to cost of sales">(691</span></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left; padding-bottom: 1pt">Amounts allocated to discounts for standalone selling price </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--AmountsAllocatedToDiscountsForStandaloneSellingPrice_pn3n3_c20240701__20250630_z8pc8cFeq9t6" title="Amounts allocated to discounts for standalone selling price">(6</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--AmountsAllocatedToDiscountsForStandaloneSellingPrice_pn3n3_c20230701__20240630_zYaZgzLbt936" title="Amounts allocated to discounts for standalone selling price">(43</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Contract assets at end of year </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ContractWithCustomerAssetNet_iE_pn3n3_c20240701__20250630_z6HzxTM10ndb" title="Contract assets at end of year">24</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--ContractWithCustomerAssetNet_iE_pn3n3_c20230701__20240630_z7ONw5SGsXs8" title="Contract assets at end of year">262</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Contract liabilities at beginning of year </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_905_eus-gaap--ContractWithCustomerLiability_iS_pn3n3_c20240701__20250630_zQOGfI3GYilc" title="Contract liabilities at beginning of year">14</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--ContractWithCustomerLiability_iS_pn3n3_c20230701__20240630_zCxvXnFGylAd" title="Contract liabilities at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl0593">—</span></span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Payments received from customers </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ProceedsFromCustomersForProgressPayments_pn3n3_c20240701__20250630_zfwbIp3hVH8j" title="Payments received from customers">202</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ProceedsFromCustomersForProgressPayments_pn3n3_c20230701__20240630_z7HRpUtq2uFb" title="Payments received from customers">267</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left; padding-bottom: 1pt">Amounts reclassified to revenue </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--AmountsReclassifiedToRevenue_pn3n3_c20240701__20250630_z8uO5R2kqneh" title="Amounts reclassified to revenue">(14</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--AmountsReclassifiedToRevenue_pn3n3_c20230701__20240630_z7Lnx5D3iPD" title="Amounts reclassified to revenue">(253</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Contract liabilities at end of year </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--ContractWithCustomerLiability_iE_pn3n3_c20240701__20250630_zoHYwx68LCUe" title="Contract liabilities at end of year">202</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--ContractWithCustomerLiability_iE_pn3n3_c20230701__20240630_zfn5eoIjWMvl" title="Contract liabilities at end of year">14</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zC9gH4XdzTfe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zvtDbtC2dX2i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NET SALES (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"><span id="xdx_8BF_zJorR6fjnl3k" style="display: none">Schedule of disaggregation of net sales</span> </span></td><td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_495_20240701__20250630_z4s2lx8SEPng" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td><td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_493_20230701__20240630_z3WoXphtyEk9" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Year ended June 30,</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-size: 8pt">2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-size: 8pt">2024</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--RevenuesAbstract_i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Net Sales:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--OvertimeRevenueRecognition_pn3n3_maRzgbR_zT9cC1tl37o2" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Over-time revenue recognition </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">698</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">786</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--PointintimeRevenueRecognition_pn3n3_maRzgbR_zRpjig0NJ7bf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in">Point-in-time revenue recognition </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">65,895</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">53,058</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--Revenues_iT_pn3n3_mtRzgbR_zYbXOdpuevbb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in">Total net sales </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">66,593</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">53,844</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 698000 786000 65895000 53058000 66593000 53844000 14000 0 <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_pn3n3_zmJ4dfyWJTyg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NET SALES (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"><span id="xdx_8BF_zTeCaJGhvhc1" style="display: none">Schedule of contract assets and liability</span> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Contract assets at beginning of year </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--ContractWithCustomerAssetNet_iS_pn3n3_c20240701__20250630_z4By6ApFXiZa" title="Contract assets at beginning of year">262</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90F_eus-gaap--ContractWithCustomerAssetNet_iS_pn3n3_c20230701__20240630_zHQOwnjSxG82" title="Contract assets at beginning of year">494</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Expenses incurred during the year </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--AccretionExpense_pn3n3_c20240701__20250630_zaTZuiTNk6E8" title="Expenses incurred during the year">228</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--AccretionExpense_pn3n3_c20230701__20240630_zeqqiupohLj9" title="Expenses incurred during the year">502</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Amounts reclassified to cost of sales </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--AmountsReclassifiedToCostOfSales_pn3n3_c20240701__20250630_z8Z5ytqUHWo3" title="Amounts reclassified to cost of sales">(460</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--AmountsReclassifiedToCostOfSales_pn3n3_c20230701__20240630_zir6p20u75Y8" title="Amounts reclassified to cost of sales">(691</span></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left; padding-bottom: 1pt">Amounts allocated to discounts for standalone selling price </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--AmountsAllocatedToDiscountsForStandaloneSellingPrice_pn3n3_c20240701__20250630_z8pc8cFeq9t6" title="Amounts allocated to discounts for standalone selling price">(6</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--AmountsAllocatedToDiscountsForStandaloneSellingPrice_pn3n3_c20230701__20240630_zYaZgzLbt936" title="Amounts allocated to discounts for standalone selling price">(43</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Contract assets at end of year </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ContractWithCustomerAssetNet_iE_pn3n3_c20240701__20250630_z6HzxTM10ndb" title="Contract assets at end of year">24</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--ContractWithCustomerAssetNet_iE_pn3n3_c20230701__20240630_z7ONw5SGsXs8" title="Contract assets at end of year">262</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Contract liabilities at beginning of year </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_905_eus-gaap--ContractWithCustomerLiability_iS_pn3n3_c20240701__20250630_zQOGfI3GYilc" title="Contract liabilities at beginning of year">14</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--ContractWithCustomerLiability_iS_pn3n3_c20230701__20240630_zCxvXnFGylAd" title="Contract liabilities at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl0593">—</span></span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Payments received from customers </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ProceedsFromCustomersForProgressPayments_pn3n3_c20240701__20250630_zfwbIp3hVH8j" title="Payments received from customers">202</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ProceedsFromCustomersForProgressPayments_pn3n3_c20230701__20240630_z7HRpUtq2uFb" title="Payments received from customers">267</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left; padding-bottom: 1pt">Amounts reclassified to revenue </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--AmountsReclassifiedToRevenue_pn3n3_c20240701__20250630_z8uO5R2kqneh" title="Amounts reclassified to revenue">(14</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--AmountsReclassifiedToRevenue_pn3n3_c20230701__20240630_z7Lnx5D3iPD" title="Amounts reclassified to revenue">(253</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Contract liabilities at end of year </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--ContractWithCustomerLiability_iE_pn3n3_c20240701__20250630_zoHYwx68LCUe" title="Contract liabilities at end of year">202</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--ContractWithCustomerLiability_iE_pn3n3_c20230701__20240630_zfn5eoIjWMvl" title="Contract liabilities at end of year">14</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 262000 494000 228000 502000 -460000 -691000 -6000 -43000 24000 262000 14000 202000 267000 -14000 -253000 202000 14000 <p id="xdx_801_eus-gaap--FairValueDisclosuresTextBlock_zzKFYDvSr1I7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>4.        <span id="xdx_820_zm9CR51ixSI8">FAIR VALUE MEASUREMENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, the use of various valuation methodologies, including market, income, and cost approaches is permissible. We consider the principal or most advantageous market in which it would transact and assumptions that market participants would use when pricing the asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt"><i>Fair Value Hierarchy</i>. The accounting guidance for fair value measurements establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value based on the reliability of inputs. A financial instrument’s categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of a particular input to the fair value measurement requires judgment and may affect their placement within the fair value hierarchy levels.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">We have categorized our cash equivalents and investments within the fair value hierarchy as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><span style="letter-spacing: 0pt"><i><span style="text-decoration: underline">Level 1</span></i> – applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. These Level 1 assets include our money market accounts, which are classified as cash equivalents. We have categorized our cash equivalents as Level 1 assets as there are quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><span style="letter-spacing: 0pt"><i><span style="text-decoration: underline">Level 2</span></i> – applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by observable market data. At June 30, 2025 and 2024, we have categorized our investments in marketable equity securities as Level 2 assets and we utilized both a protective put option and a time-adjusted discount for the lack of marketability valuation method to estimate fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 40pt; text-indent: 0pt; text-align: justify"><span style="letter-spacing: 0pt"><i><span style="text-decoration: underline">Level 3</span></i> – applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. We held no Level 3 assets or liabilities at June 30, 2025 or 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="letter-spacing: 0pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--MarketableSecuritiesTableTextBlock_pn3n3_zwSDz8wZPNPb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"><span id="xdx_8BE_zil08jJwPTU3" style="display: none">Schedule of marketable equity</span> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Fair Value Measurement at June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left">Financial Assets:</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Cash equivalents </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zCvoHeG5sLg9" title="Cash equivalents">33</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z11uZlkfpElh" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0615">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAIsREscRzXi" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0617">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20250630_z2yuYlH9OWVl" title="Cash equivalents">33</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Marketable equity securities – short-term </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zRDP0UPsBfi1" title="Marketable Securities, Current"><span style="-sec-ix-hidden: xdx2ixbrl0621">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLyII3LwV614" title="Marketable Securities, Current">6,740</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZVOqr9C33c8" title="Marketable Securities, Current"><span style="-sec-ix-hidden: xdx2ixbrl0625">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20250630_zKSr4rCsn0yh" title="Marketable Securities, Current">6,740</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Marketable equity securities – long-term </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbZuMR2AxZT5" title="Marketable Securities, Noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0629">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbcKsQG6lrb" title="Marketable Securities, Noncurrent">148</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdQEl00QXid5" title="Marketable Securities, Noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0633">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20250630_zrvhuvkC3lN8" title="Marketable Securities, Noncurrent">148</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -0.3in; padding-left: 0.3in"> Total </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKS9HATMOAZ9" title="Total">33</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWdrKZ6CoV0j" title="Total">6,888</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zu0MlQF4htw" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0641">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630_z5C3nIiBcqpf" title="Total">6,921</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Fair Value Measurement at June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="14" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left; width: 48%">Cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zACEzsbBFbc7" title="Cash equivalents">45</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_902_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXeG1kjsXkb8" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0647">—</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zL1EXwxGxsxi" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0649">—</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20240630_zisRsD05SUa7" title="Cash equivalents">45</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Marketable equity securities – short-term </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_znH8D8Y513Xi" title="Marketable Securities, Current"><span style="-sec-ix-hidden: xdx2ixbrl0653">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzT3WBcs28mj" title="Marketable Securities, Current">4,217</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOpgmDwdtGC" title="Marketable Securities, Current"><span style="-sec-ix-hidden: xdx2ixbrl0657">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20240630_z26vQnsC19s4" title="Marketable Securities, Current">4,217</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Marketable equity securities – long-term </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z74Fr1CrsyL" title="Marketable Securities, Noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0661">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zUoLP7rF7VHd" title="Marketable Securities, Noncurrent">1,563</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPVEfLPf8Fwi" title="Marketable Securities, Noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0665">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20240630_zdQa1SOPWIti" title="Marketable Securities, Noncurrent">1,563</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -0.3in; padding-left: 0.3in">Total </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zFgm2OIwSYk7" title="Total">45</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7p4F4VcPVy2" title="Total">5,780</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMC74H8cajbg" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0673">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630_zRik5qqUeUEi" title="Total">5,825</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p> <p id="xdx_8AF_zvbCvmOSwDj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Marketable equity securities at June 30, 2025 and 2024 had an aggregate cost basis</span> of <span style="letter-spacing: 0pt">$<span id="xdx_90E_ecustom--AvailableForSaleSecuritiesAmortizedCosts_c20250630_pp0p" title="Available for sale securities aggregate cost">3,551,000</span> and $<span id="xdx_90D_ecustom--AvailableForSaleSecuritiesAmortizedCosts_c20240630_pp0p" title="Available for sale securities aggregate cost">3,964,000</span>,</span> respectively. Both current and long-term marketable equity securities include equity securities of public companies that are thinly traded. We classified certain investments as long term in nature because even if we decide to sell the stocks, we may not be able to sell our position within one year. At June 30, 2025, the investments included net unrealized gains of $<span id="xdx_905_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_pn5n6_c20240701__20250630_zWO3UnPlCKYh" title="Investments included net unrealized gains (losses)">3.3</span> million (gross unrealized gains of $<span id="xdx_906_ecustom--MarketableSecuritiesUnrealizedGain_pn5n6_c20240701__20250630_zDZhQ6r7Av7" title="Gross unrealized gains">3.5</span> million offset by gross unrealized losses of $<span id="xdx_904_ecustom--MarketableSecuritiesUnrealizedLoss_pp0d_c20240701__20250630_zxkIHZrwdD4l" title="Gross unrealized losses">213,000</span>). At June 30, 2024, the investments included net unrealized gains of $<span id="xdx_90C_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_pn5n6_c20230701__20240630_ztwC4ZZYou2h" title="Investments included net unrealized gains (losses)">1.8</span> million (gross unrealized gains of $<span id="xdx_904_ecustom--MarketableSecuritiesUnrealizedGain_pn5n6_c20230701__20240630_zQwlLm1FRwEa" title="Gross unrealized gains">2.1</span> million offset by gross unrealized losses of $<span id="xdx_902_ecustom--MarketableSecuritiesUnrealizedLoss_pp0d_c20230701__20240630_zdCmkTsx63fa" title="Gross unrealized losses">261,000</span>).</p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Of the total marketable equity securities at June 30, 2025 and 2024, $<span id="xdx_90D_eus-gaap--OtherShortTermInvestments_iI_pn5n6_c20250630_zATijFOeXBS" title="Marketable equity securities">1.0</span> million and $<span id="xdx_907_eus-gaap--OtherShortTermInvestments_c20240630_pp0p" title="Marketable equity securities">987,000</span>, respectively, represent an investment in the common stock of Air T, Inc. Two of our Board members, Messrs. Swenson and Cabillot, are also board members of Air <span style="letter-spacing: 0pt">T, Inc. and both either individually or through affiliates own an equity interest in Air T, Inc. Mr. Swenson, our Chairman, also serves as the chief executive officer and chairman of Air T, Inc. Another of our Board members is employed by Air T as its Chief of Staff. The shares have been purchased through 10b5-1 Plans that, in accordance with our internal policies regarding the approval of related-party transactions, were approved by our then three Board members that are not affiliated with Air T, Inc.</span></p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_908_ecustom--WarrantDescription_c20231001__20231006_z3Swef43nLn7" title="Warrant description">On October 6, 2023, in conjunction with the execution of a supply agreement with Monogram Technologies, Inc., formerly Monogram Orthopaedics Inc. (“Monogram”), we exercised a warrant to purchase common stock of Monogram (the “Monogram Warrant”) in full in cash totaling $1,250,000 and received 1,828,551 shares of Monogram common stock (NasdaqCM: MGRM). Additionally, in June 2025 we exercised additional warrants in full in cash totaling $900,000 and received an additional 85,705 shares of common stock and 298,122 shares of Series D Preferred Stock. On July 14, 2025, the Series D preferred stock converted into the same number of common shares pursuant to the terms of the underlying certificate. The fair value of the Monogram common stock and preferred stock is reflected in marketable equity securities – short term in the tables above.</span> Our Chief Executive Officer, Mr. Van Kirk, is also a Monogram board member.</p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We invest surplus cash from time to time through our Investment Committee, which is comprised of one management director, Mr. Van Kirk, and two non-management directors, Mr. Cabillot and Mr. Swenson, who chairs the committee. Both Messrs. Cabillot and Swenson are active investors with extensive portfolio management expertise. We leverage the experience of these committee members to make investment decisions for the investment of our surplus operating capital or borrowed funds. Additionally, many of our securities holdings include stocks of public companies that either Messrs. Swenson or Cabillot or both may own from time to time either individually or through the investment funds that they manage, or other companies whose boards they sit on, such as Air T, Inc.</p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--MarketableSecuritiesTableTextBlock_pn3n3_zwSDz8wZPNPb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"><span id="xdx_8BE_zil08jJwPTU3" style="display: none">Schedule of marketable equity</span> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Fair Value Measurement at June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left">Financial Assets:</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Cash equivalents </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zCvoHeG5sLg9" title="Cash equivalents">33</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z11uZlkfpElh" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0615">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zAIsREscRzXi" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0617">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20250630_z2yuYlH9OWVl" title="Cash equivalents">33</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Marketable equity securities – short-term </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zRDP0UPsBfi1" title="Marketable Securities, Current"><span style="-sec-ix-hidden: xdx2ixbrl0621">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLyII3LwV614" title="Marketable Securities, Current">6,740</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZVOqr9C33c8" title="Marketable Securities, Current"><span style="-sec-ix-hidden: xdx2ixbrl0625">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20250630_zKSr4rCsn0yh" title="Marketable Securities, Current">6,740</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Marketable equity securities – long-term </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbZuMR2AxZT5" title="Marketable Securities, Noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0629">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbcKsQG6lrb" title="Marketable Securities, Noncurrent">148</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdQEl00QXid5" title="Marketable Securities, Noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0633">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20250630_zrvhuvkC3lN8" title="Marketable Securities, Noncurrent">148</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -0.3in; padding-left: 0.3in"> Total </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKS9HATMOAZ9" title="Total">33</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWdrKZ6CoV0j" title="Total">6,888</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zu0MlQF4htw" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0641">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630_z5C3nIiBcqpf" title="Total">6,921</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Fair Value Measurement at June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="14" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left; width: 48%">Cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zACEzsbBFbc7" title="Cash equivalents">45</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_902_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXeG1kjsXkb8" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0647">—</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zL1EXwxGxsxi" title="Cash equivalents"><span style="-sec-ix-hidden: xdx2ixbrl0649">—</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_901_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_c20240630_zisRsD05SUa7" title="Cash equivalents">45</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Marketable equity securities – short-term </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_znH8D8Y513Xi" title="Marketable Securities, Current"><span style="-sec-ix-hidden: xdx2ixbrl0653">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzT3WBcs28mj" title="Marketable Securities, Current">4,217</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOpgmDwdtGC" title="Marketable Securities, Current"><span style="-sec-ix-hidden: xdx2ixbrl0657">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--MarketableSecuritiesCurrent_iI_pn3n3_c20240630_z26vQnsC19s4" title="Marketable Securities, Current">4,217</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Marketable equity securities – long-term </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z74Fr1CrsyL" title="Marketable Securities, Noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0661">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zUoLP7rF7VHd" title="Marketable Securities, Noncurrent">1,563</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPVEfLPf8Fwi" title="Marketable Securities, Noncurrent"><span style="-sec-ix-hidden: xdx2ixbrl0665">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--MarketableSecuritiesNoncurrent_iI_pn3n3_c20240630_zdQa1SOPWIti" title="Marketable Securities, Noncurrent">1,563</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -0.3in; padding-left: 0.3in">Total </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zFgm2OIwSYk7" title="Total">45</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7p4F4VcPVy2" title="Total">5,780</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMC74H8cajbg" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl0673">—</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630_zRik5qqUeUEi" title="Total">5,825</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p> 33000 33000 6740000 6740000 148000 148000 33000 6888000 6921000 45000 45000 4217000 4217000 1563000 1563000 45000 5780000 5825000 3551000 3964000 3300000 3500000 213000 1800000 2100000 261000 1000000.0 987000 On October 6, 2023, in conjunction with the execution of a supply agreement with Monogram Technologies, Inc., formerly Monogram Orthopaedics Inc. (“Monogram”), we exercised a warrant to purchase common stock of Monogram (the “Monogram Warrant”) in full in cash totaling $1,250,000 and received 1,828,551 shares of Monogram common stock (NasdaqCM: MGRM). Additionally, in June 2025 we exercised additional warrants in full in cash totaling $900,000 and received an additional 85,705 shares of common stock and 298,122 shares of Series D Preferred Stock. On July 14, 2025, the Series D preferred stock converted into the same number of common shares pursuant to the terms of the underlying certificate. The fair value of the Monogram common stock and preferred stock is reflected in marketable equity securities – short term in the tables above. <p id="xdx_803_eus-gaap--AdditionalFinancialInformationDisclosureTextBlock_zZIIaDbuPgQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5.        <span id="xdx_821_zD35pV9SWiEc">COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"><b>Inventory</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Inventory is stated at the lower of cost (first-in, first-out) or net realizable value and consists of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zYArLOcXXxf1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 8pt"> <span id="xdx_8B7_zgmhhHo8c1c6" style="display: none">Schedule of inventory</span></span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td id="xdx_491_20250630_zKRGCVk2LgJ3" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td id="xdx_492_20240630_zs4qXYLumHa1" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINz6dX_zMiNSOu8vWii" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Raw materials /purchased components </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">10,397</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">6,703</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maINz6dX_zKOSRrJigWZ8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,422</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,103</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--InventorySubAssemblies_iI_pn3n3_maINz6dX_zs7RaSdYWPbh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sub-assemblies /finished components </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,874</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,342</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINz6dX_zf4WpcqH57g4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,520</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,121</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pn3n3_mtINz6dX_z6iXkE744R81" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventory </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">22,213</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,269</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zbQOqYw3WdGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"><b>Land and Building</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Land and building consist of the following (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--LandAndBuildingTableTextBlock_pn3n3_zAmARdEfoJy1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8B3_zYs3sgzEyFxl" style="display: none">Schedule of land and building</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">Land </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zNq2FNNpVlBj" title="Land and building, gross">3,684</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zLTtKFOJjIdc" title="Land and building, gross">3,684</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Building </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zHX6TAup3R0c" title="Land and building, gross">2,815</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zcwJ8FxymtP8" title="Land and building, gross">2,815</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Total </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630_zscq1UulFCq2" title="Land and building, gross">6,499</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zMEzsvGVHSA2" title="Land and building, gross">6,499</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--AccumulatedDepreciation_iI_pn3n3_c20250630_zHzaem0RukDj" title="Less: accumulated depreciation">(438</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_ecustom--AccumulatedDepreciation_iI_pn3n3_c20240630_zVbYEoj3LLKd" title="Less: accumulated depreciation">(344</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentOtherNet_iI_pn3n3_c20250630_zdicFYqWkqH1" title="Land and building, net">6,061</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentOtherNet_iI_pn3n3_c20240630_zGmAwmGm8ra3" title="Land and building, net">6,155</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_z3OzKyJLx1hl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">On November 6, 2020, we acquired the Franklin Property in order to increase our operational capacity for a total purchase price of $<span id="xdx_90C_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_pn5n6_c20201105__20201106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FranklinMember_ztWJFSiQ7Sqf" title="Payment to acquired property plant equipment">6.5</span> million, of which we paid $<span id="xdx_907_eus-gaap--PaymentsToAcquireOtherPropertyPlantAndEquipment_pn5n6_c20201105__20201106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FranklinMember_zMrzfvyvSrLe" title="Payment of property plant equipment">1.3</span> million in cash and the balance of $<span id="xdx_909_ecustom--BankFinanced_pn5n6_c20201105__20201106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FranklinMember_zroefI4Kgaw9" title="Bank financed">5.2</span> million we financed (the “Property Loan”) through Minnesota Bank &amp; Trust (“MBT”) (See Note 8). Depreciation expense for both fiscal years ended June 30, 2025 and 2024 totaled $<span id="xdx_90B_eus-gaap--Depreciation_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FranklinMember_zwAS10uOs2nb" title="Depreciation expense"><span id="xdx_90A_eus-gaap--Depreciation_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FranklinMember_zJblNQEiCRka" title="Depreciation expense">94,000</span></span>. The building is being amortized on a straight-line basis over a period of <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FranklinMember_zuchMwCXelvg" title="Useful life">30</span> years.</span></p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"><b>Equipment and Improvements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Equipment and improvements consist of the following (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_z7jgn8eThiFj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 2)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8BA_z1gK2XW9Wrkg" style="display: none">Schedule of equipment and improvements</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Office furnishings and fixtures </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zl6doxrwjIdc" title="Equipment and improvements, gross">2,078</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zpLKsIEiEQj2" title="Equipment and improvements, gross">1,982</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Machinery and equipment </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zomJdGqzTT2" title="Equipment and improvements, gross">8,198</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_ztJC8CAAT133" title="Equipment and improvements, gross">7,292</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Automobiles </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_zKfMschQW9y5" title="Equipment and improvements, gross">21</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_zG9CrnwAwlYi" title="Equipment and improvements, gross">21</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Improvements </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdsAndLeaseholdImprovementsMember_zrHMHs9hLAc9" title="Equipment and improvements, gross">5,205</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdsAndLeaseholdImprovementsMember_zo5VvZbJXZU6" title="Equipment and improvements, gross">4,993</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Total </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630_zx0bCZsenJJf" title="Equipment and improvements, gross">15,502</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630_zd4y0A9IGyI4" title="Equipment and improvements, gross">14,288</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation and amortization </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20250630_z67CsJKsRzDe" title="Less: accumulated depreciation and amortization">(10,349</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20240630_z7KlRU6sm0k6" title="Less: accumulated depreciation and amortization">(9,264</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630_zcNrYzZBbpvb" title="Equipment and improvements, net">5,153</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zTHbwAjaos44" title="Equipment and improvements, net">5,024</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_ztaDS049bht2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Depreciation expense for the years ended June 30, 2025 and 2024 amounted to $<span id="xdx_90C_eus-gaap--Depreciation_pn5n6_c20240701__20250630_zXJMVgXoJYCk" title="Depreciation expenses">1.1</span> million and $<span id="xdx_906_eus-gaap--Depreciation_pn5n6_c20230701__20240630_zXmKiCruWdog" title="Depreciation expenses">1.0</span> million, respectively. During fiscal 2025 and 2024, fully depreciated assets in the amount of $<span id="xdx_908_ecustom--RetiredAssets_c20250630_pp0p" title="Retired assets">32,000</span> and $<span id="xdx_907_ecustom--RetiredAssets_c20240630_pp0p" title="Retired assets">85,000</span>, respectively, were retired. </span></p> <p style="font: 10pt/11.2pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"><b>Intangibles</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="letter-spacing: 0pt">Intangibles consist of the following (in thousands): </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="letter-spacing: 0pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zTlyeu7oNUy2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 3)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8BA_zFnjni2DHmg3" style="display: none">Schedule of intangibles</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Patent-related costs </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_905_eus-gaap--FiniteLivedPatentsGross_iI_pn3n3_c20250630_zJnhQT4Au2Zd" title="Patent-related costs">208</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--FiniteLivedPatentsGross_iI_pn3n3_c20240630_z03Iwjpabl3e" title="Patent-related costs">208</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated amortization </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20250630_zTJEVj6vs8Z1" title="Less accumulated amortization">(182</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630_zeb1IwNHFWgi" title="Less accumulated amortization">(154</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20250630_zZXFfwGpUaf1" title="Intangible assets,net">26</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630_zXQR6f5SrkFe" title="Intangible assets,net">54</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zBdO0N060ZX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Patent-related costs consist of legal fees incurred in connection with both patent applications and patent issuances, and will be amortized over the estimated life of the product(s) that is or will be utilizing the technology, or expensed immediately in the event the patent office denies the issuance of the patent. All remaining costs are expected to be fully amortized in fiscal 2026. Amortization expense for both years ended June 30, 2025 and 2024 totaled $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20240701__20250630_pp0p" title="Amortization expense"><span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20230701__20240630_pp0p" title="Amortization expense">28,000</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"><b>Accrued Liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accrued liabilities consist of the following (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_pn3n3_zP7aYSgIlJPb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 4)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8B0_zdROES3w7139" style="display: none">Schedule of accrued liabilities</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_499_20250630_z2ASiG9WbvHa" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_49F_20240630_zsJfRQLbfgw4" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maALCzWdL_zrI2OuTD2d68" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Payroll and related items </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">850</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">668</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--UnvoucheredInventoryInTransitCurrent_iI_pn3n3_maALCzWdL_zfkxiEwUriZf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued inventory in transit </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">276</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maALCzWdL_z4ntmo01sMEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued legal and professional fees </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">267</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">301</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccruedBonusesCurrent_iI_pn3n3_maALCzWdL_zwOnMp72H663" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued bonuses </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">501</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">353</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--OperatingLeaseLiabilityCurrents_iI_pn3n3_maALCzWdL_zYthvYI153Lk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion of lease liability </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">498</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">455</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pn3n3_maALCzWdL_zpgFed1Q27fb" style="vertical-align: bottom; background-color: White"> <td>Warranty </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">357</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">277</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--AccruedLossesOnDevelopmentContractsCurrent_iI_pn3n3_maALCzWdL_zOAqUoUNLuh4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued customer rebate </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">840</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCzWdL_zvSs2iinHMLg" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">229</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">189</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCzWdL_zDGeTcqi0yD3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); padding-bottom: 2.5pt"> Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,479</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,359</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zJx9PJ0wiBE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zYArLOcXXxf1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 8pt"> <span id="xdx_8B7_zgmhhHo8c1c6" style="display: none">Schedule of inventory</span></span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td id="xdx_491_20250630_zKRGCVk2LgJ3" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td id="xdx_492_20240630_zs4qXYLumHa1" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINz6dX_zMiNSOu8vWii" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Raw materials /purchased components </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">10,397</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">6,703</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maINz6dX_zKOSRrJigWZ8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,422</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,103</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--InventorySubAssemblies_iI_pn3n3_maINz6dX_zs7RaSdYWPbh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sub-assemblies /finished components </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,874</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,342</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINz6dX_zf4WpcqH57g4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,520</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,121</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pn3n3_mtINz6dX_z6iXkE744R81" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventory </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">22,213</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,269</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 10397000 6703000 7422000 5103000 2874000 2342000 1520000 1121000 22213000 15269000 <table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--LandAndBuildingTableTextBlock_pn3n3_zAmARdEfoJy1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 1)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8B3_zYs3sgzEyFxl" style="display: none">Schedule of land and building</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">Land </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zNq2FNNpVlBj" title="Land and building, gross">3,684</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zLTtKFOJjIdc" title="Land and building, gross">3,684</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Building </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zHX6TAup3R0c" title="Land and building, gross">2,815</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zcwJ8FxymtP8" title="Land and building, gross">2,815</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Total </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630_zscq1UulFCq2" title="Land and building, gross">6,499</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zMEzsvGVHSA2" title="Land and building, gross">6,499</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--AccumulatedDepreciation_iI_pn3n3_c20250630_zHzaem0RukDj" title="Less: accumulated depreciation">(438</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_ecustom--AccumulatedDepreciation_iI_pn3n3_c20240630_zVbYEoj3LLKd" title="Less: accumulated depreciation">(344</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentOtherNet_iI_pn3n3_c20250630_zdicFYqWkqH1" title="Land and building, net">6,061</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentOtherNet_iI_pn3n3_c20240630_zGmAwmGm8ra3" title="Land and building, net">6,155</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3684000 3684000 2815000 2815000 6499000 6499000 -438000 -344000 6061000 6155000 6500000 1300000 5200000 94000 94000 P30Y <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_z7jgn8eThiFj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 2)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8BA_z1gK2XW9Wrkg" style="display: none">Schedule of equipment and improvements</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Office furnishings and fixtures </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zl6doxrwjIdc" title="Equipment and improvements, gross">2,078</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zpLKsIEiEQj2" title="Equipment and improvements, gross">1,982</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Machinery and equipment </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zomJdGqzTT2" title="Equipment and improvements, gross">8,198</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_ztJC8CAAT133" title="Equipment and improvements, gross">7,292</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Automobiles </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_zKfMschQW9y5" title="Equipment and improvements, gross">21</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--AutomobilesMember_zG9CrnwAwlYi" title="Equipment and improvements, gross">21</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Improvements </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdsAndLeaseholdImprovementsMember_zrHMHs9hLAc9" title="Equipment and improvements, gross">5,205</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdsAndLeaseholdImprovementsMember_zo5VvZbJXZU6" title="Equipment and improvements, gross">4,993</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Total </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20250630_zx0bCZsenJJf" title="Equipment and improvements, gross">15,502</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240630_zd4y0A9IGyI4" title="Equipment and improvements, gross">14,288</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation and amortization </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20250630_z67CsJKsRzDe" title="Less: accumulated depreciation and amortization">(10,349</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20240630_z7KlRU6sm0k6" title="Less: accumulated depreciation and amortization">(9,264</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630_zcNrYzZBbpvb" title="Equipment and improvements, net">5,153</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zTHbwAjaos44" title="Equipment and improvements, net">5,024</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2078000 1982000 8198000 7292000 21000 21000 5205000 4993000 15502000 14288000 10349000 9264000 5153000 5024000 1100000 1000000.0 32000 85000 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zTlyeu7oNUy2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 3)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8BA_zFnjni2DHmg3" style="display: none">Schedule of intangibles</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Patent-related costs </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_905_eus-gaap--FiniteLivedPatentsGross_iI_pn3n3_c20250630_zJnhQT4Au2Zd" title="Patent-related costs">208</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--FiniteLivedPatentsGross_iI_pn3n3_c20240630_z03Iwjpabl3e" title="Patent-related costs">208</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated amortization </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20250630_zTJEVj6vs8Z1" title="Less accumulated amortization">(182</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_c20240630_zeb1IwNHFWgi" title="Less accumulated amortization">(154</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20250630_zZXFfwGpUaf1" title="Intangible assets,net">26</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_c20240630_zXQR6f5SrkFe" title="Intangible assets,net">54</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 208000 208000 -182000 -154000 26000 54000 28000 28000 <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_pn3n3_zP7aYSgIlJPb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 4)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8B0_zdROES3w7139" style="display: none">Schedule of accrued liabilities</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_499_20250630_z2ASiG9WbvHa" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_49F_20240630_zsJfRQLbfgw4" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maALCzWdL_zrI2OuTD2d68" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Payroll and related items </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">850</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">668</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--UnvoucheredInventoryInTransitCurrent_iI_pn3n3_maALCzWdL_zfkxiEwUriZf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued inventory in transit </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">276</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maALCzWdL_z4ntmo01sMEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued legal and professional fees </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">267</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">301</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccruedBonusesCurrent_iI_pn3n3_maALCzWdL_zwOnMp72H663" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued bonuses </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">501</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">353</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--OperatingLeaseLiabilityCurrents_iI_pn3n3_maALCzWdL_zYthvYI153Lk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion of lease liability </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">498</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">455</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pn3n3_maALCzWdL_zpgFed1Q27fb" style="vertical-align: bottom; background-color: White"> <td>Warranty </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">357</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">277</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--AccruedLossesOnDevelopmentContractsCurrent_iI_pn3n3_maALCzWdL_zOAqUoUNLuh4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued customer rebate </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">690</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">840</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCzWdL_zvSs2iinHMLg" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">229</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">189</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCzWdL_zDGeTcqi0yD3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); padding-bottom: 2.5pt"> Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,479</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,359</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 850000 668000 87000 276000 267000 301000 501000 353000 498000 455000 357000 277000 690000 840000 229000 189000 3479000 3359000 <p id="xdx_803_eus-gaap--ProductWarrantyDisclosureTextBlock_zyNoi5ZygGUj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6.        <span id="xdx_82D_z6dAx0VdalVe">WARRANTY ACCRUAL</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt/11.3pt Times New Roman, Times, Serif; margin: 0pt 14.85pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Information relating to the accrual for warranty costs for the years ended June 30, 2025 and 2024, is as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_pn3n3_z5dFjEk41UGb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTY ACCRUAL (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8BA_zVWUWDPoH5Ld" style="display: none">Schedule of accrual warranty costs</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Balance at beginning of year </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_907_eus-gaap--ProductWarrantyAccrual_iS_pn3n3_c20240701__20250630_z7Zq50WciP59" title="Balance at beginning of year">277</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_904_eus-gaap--ProductWarrantyAccrual_iS_pn3n3_c20230701__20240630_zGov7nzF2XA" title="Balance at beginning of year">200</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">      Accruals during the year </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pn3n3_c20240701__20250630_zTVr12EabuSk" title="Accruals during the year">336</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pn3n3_c20230701__20240630_zOVXdnsSPzQ" title="Accruals during the year">197</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">      Change in estimates of prior period accruals </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ProductWarrantyAccrualPreexistingIncreaseDecrease_pn3n3_c20240701__20250630_zhQOFO3xzCDj" title="Change in estimates of prior period accruals">(84</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ProductWarrantyAccrualPreexistingIncreaseDecrease_pn3n3_c20230701__20240630_zxqDzSi9oghd" title="Change in estimates of prior period accruals">70</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">      Warranty amortization/utilization </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_ecustom--ProductWarrantyAccrualAmortization_pn3n3_c20240701__20250630_zT1wbq7RpMRe" title="Warranty amortization/utilization">(172</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--ProductWarrantyAccrualAmortization_pn3n3_c20230701__20240630_z8NLaTC3qPH4" title="Warranty amortization/utilization">(190</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Balance at end of year </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--ProductWarrantyAccrual_iE_pn3n3_c20240701__20250630_zEUsSjDi6vA4" title="Balance at end of year">357</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--ProductWarrantyAccrual_iE_pn3n3_c20230701__20240630_z6v6sKJ99Gaj" title="Balance at end of year">277</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_pn3n3_z5dFjEk41UGb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTY ACCRUAL (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8BA_zVWUWDPoH5Ld" style="display: none">Schedule of accrual warranty costs</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Balance at beginning of year </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_907_eus-gaap--ProductWarrantyAccrual_iS_pn3n3_c20240701__20250630_z7Zq50WciP59" title="Balance at beginning of year">277</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_904_eus-gaap--ProductWarrantyAccrual_iS_pn3n3_c20230701__20240630_zGov7nzF2XA" title="Balance at beginning of year">200</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">      Accruals during the year </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pn3n3_c20240701__20250630_zTVr12EabuSk" title="Accruals during the year">336</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pn3n3_c20230701__20240630_zOVXdnsSPzQ" title="Accruals during the year">197</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">      Change in estimates of prior period accruals </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ProductWarrantyAccrualPreexistingIncreaseDecrease_pn3n3_c20240701__20250630_zhQOFO3xzCDj" title="Change in estimates of prior period accruals">(84</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ProductWarrantyAccrualPreexistingIncreaseDecrease_pn3n3_c20230701__20240630_zxqDzSi9oghd" title="Change in estimates of prior period accruals">70</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">      Warranty amortization/utilization </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_ecustom--ProductWarrantyAccrualAmortization_pn3n3_c20240701__20250630_zT1wbq7RpMRe" title="Warranty amortization/utilization">(172</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--ProductWarrantyAccrualAmortization_pn3n3_c20230701__20240630_z8NLaTC3qPH4" title="Warranty amortization/utilization">(190</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Balance at end of year </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--ProductWarrantyAccrual_iE_pn3n3_c20240701__20250630_zEUsSjDi6vA4" title="Balance at end of year">357</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--ProductWarrantyAccrual_iE_pn3n3_c20230701__20240630_z6v6sKJ99Gaj" title="Balance at end of year">277</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 277000 200000 336000 197000 -84000 70000 -172000 -190000 357000 277000 <p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zJYldEeNPmvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7. <span id="xdx_825_z11j2CmzCeU6">INCOME TAXES</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt/97% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provision for income taxes consists of the following amounts (in thousands):</p> <p style="font: 10pt/97% Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_pn3n3_zxghW32Ok1H3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8B1_zq56ax5j2lci" style="display: none">Schedule of provision for income taxes</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_496_20240701__20250630_zK9Xb8WVAiIc" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_49F_20230701__20240630_ziCV89Jj0ywg" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zmvMxraENCB" style="vertical-align: bottom"> <td>Current:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pn3n3_zCDcNEsySwUi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; width: 66%">Federal </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,114</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,493</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pn3n3_zMVO9vTZDHca" style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">State </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">826</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">577</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zuovlBaQ3iA3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pn3n3_zyjiU2OnYnCh" style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">Federal </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,210</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pn3n3_zAfUKAfbom4d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; padding-bottom: 1pt">State </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">64</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(353</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_zHpUpxejd2Zi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,080</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">507</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z00xyuAZGcm8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The effective income tax rate from income from continuing operations differs from the United States statutory income tax rates for the reasons set forth in the table below (in thousands, except percentages).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_pn3n3_zTSES4Oce9zk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8B4_z51gjeB0vsJ8" style="display: none">Schedule of reconciliation federal statutory income tax rates</span></span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Percent Pretax Income</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Percent Pretax Income</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Income before income taxes </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630_z8DHLY7mgjug" title="Income before income taxes">12,058</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_908_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestTaxRate_pid_dp_c20240701__20250630_zM8h5cayPcOd" title="Income before income taxes, Percent pretax income">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630_zcGnV7RtIw96" title="Income before income taxes">2,634</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_903_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestTaxRate_pid_dp_c20230701__20240630_z9pkAoaoTNvk" title="Income before income taxes, Percent pretax income">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Computed “expected” income tax expense on income before income taxes </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRates_pn3n3_c20240701__20250630_zDCvgcefc8sa" title="Computed &quot;expected&quot; income tax expense on income before income taxes">2,532</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_pid_dp_c20240701__20250630_z2WCacRfedz7" title="Computed &quot;expected&quot; income tax expense on income before income taxes, Percent pretax income">21</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRates_pn3n3_c20230701__20240630_zRvz47yzm6ca" title="Computed &quot;expected&quot; income tax expense on income before income taxes">553</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_pid_dp_c20230701__20240630_zU1akSqlSH1j" title="Computed &quot;expected&quot; income tax expense on income before income taxes, Percent pretax income">21</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">State tax, net of federal benefit </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_c20240701__20250630_zylegQF48G11" title="State tax, net of federal benefit">964</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_c20240701__20250630_zYXDG6tfEGR8" title="State tax, net of federal benefit, Percent pretax income">8</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_c20230701__20240630_z4hTzAd8sfY1" title="State tax, net of federal benefit">212</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_c20230701__20240630_zWCAyW6lYFe2" title="State tax, net of federal benefit, Percent pretax income">8</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Tax incentives </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--IncomeTaxReconciliationTaxExemptIncome_pn3n3_c20240701__20250630_zNrrP2yLTTb6" title="Tax incentives">(149</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxExemptIncome_pid_dp_c20240701__20250630_zGkrpyWdsXG3" title="Tax incentives, Percent pretax income">(1</span></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--IncomeTaxReconciliationTaxExemptIncome_pn3n3_c20230701__20240630_z6lfzu3UpKZ8" title="Tax incentives">(214</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxExemptIncome_pid_dp_c20230701__20240630_zNkHwvgShXFd" title="Tax incentives, Percent pretax income">(8</span></td><td style="text-align: left">%)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Uncertain tax position </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--UncertainTaxPositions_pn3n3_c20240701__20250630_zCoM4fiB2oQ9" title="Uncertain tax position">(116</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--UncertainTaxPosition_pid_dp_c20240701__20250630_z9oVFrGXlz35" title="Uncertain tax position, Percent pretax income">(1</span></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--UncertainTaxPositions_pn3n3_c20230701__20240630_zEdHpMspuNoh" title="Uncertain tax position">(88</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--UncertainTaxPosition_pid_dp_c20230701__20240630_ztMufoyPcgRh" title="Uncertain tax position, Percent pretax income">(3</span></td><td style="text-align: left">%)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Stock based compensation </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--IncomeTaxReconciliationShareBasedCompensation_pn3n3_c20240701__20250630_zfrhXBAxwHUe" title="Share based compensation">(164</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_c20240701__20250630_z5jviWrXNTRj" title="Share based compensation, Percent pretax income">(1</span></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--IncomeTaxReconciliationShareBasedCompensation_pn3n3_c20230701__20240630_zBN4p3fmRQe8" title="Share based compensation">2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp0_c20230701__20240630_zLkooWHMukja" title="Share based compensation, Percent pretax income">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Other </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_pn3n3_c20240701__20250630_z6g5SlNDlzui" title="Other">13</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_pid_dp0_c20240701__20250630_zJPGTl6pBk3g" title="Other, Percent pretax income">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_pn3n3_c20230701__20240630_zHfLHy88Qgte" title="Other">42</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_pid_dp_c20230701__20240630_zySmhsMArrdg" title="Other, Percent pretax income">1</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Income tax expense </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20240701__20250630_zRvTIcfSEOLc" title="Income tax expense">3,080</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20240701__20250630_z91Gy2x0v39k" title="Income tax expense, Percent pretax income">26</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20230701__20240630_zp1pedpZUYNc" title="Income tax expense">507</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20230701__20240630_zd8Od3j0vgul" title="Income tax expense, Percent pretax income">19</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8A9_zVnqVVgv1cz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deferred income taxes reflect the net effects of loss and credit carryforwards and temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities for federal and state income taxes are as follows (in thousands):</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_zA80XnUfjjt3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span id="xdx_8BF_z1LYqscVVPh6" style="display: none">Schedule of deferred income tax assets and liabilities</span><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_499_20250630_zMw9FZBRzVp8" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_499_20240630_zWm47pNnsUU2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zql4M2diEaE1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pn3n3_maDTAGzZtz_znlqBBYoXvJ7" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Federal and state NOL carryforward </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">23</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">23</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--DeferredTaxAssetsResearchAndOtherCredits_i01I_pn3n3_maDTAGzZtz_zZiRhYBeeqfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Research and other credits </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_i01I_pn3n3_maDTAGzZtz_z1xh4DEWD5y3" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9.35pt; padding-left: 18.7pt">Reserves </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">170</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">146</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_i01I_pn3n3_maDTAGzZtz_z99JHtShWMF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9.35pt; padding-left: 18.7pt">Accruals </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">436</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">309</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_pn3n3_maDTAGzZtz_zn5Sig4Wp1Qe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Stock based compensation </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,096</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,008</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--Section174Capitalization_i01I_pn3n3_maDTAGzZtz_zMMyUuAg72Ph" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Section 174 capitalization </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">756</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">738</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--DeferredTaxAssetLeaseLiability_i01I_pn3n3_maDTAGzZtz_zhksm673Vafa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Lease liability </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">353</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">488</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsInventory_i01I_pn3n3_maDTAGzZtz_zd5ZTByuNRN8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9.35pt; padding-left: 18.7pt">Inventory </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">614</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">596</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsOther_i01I_pn3n3_maDTAGzZtz_zCBZtBYFxDej" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Other </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_i01TI_pn3n3_mtDTAGzZtz_maDTANz1YX_zB5p1id9V4K6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Total gross deferred tax assets </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,525</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,378</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pn3n3_di_msDTANz1YX_z4k2Ef3AljFh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Less: valuation allowance </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(90</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(90</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_i01TI_pn3n3_mtDTANz1YX_maDTALNzok3_zlzY3YNRFJf8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9.35pt; padding-left: 18.7pt">Total deferred tax assets </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,435</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,288</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_z7rmPPrTNEtb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pn3n3_di_maDITLzBv6_zjdDl88MWhUd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Property and equipment, principally due to differing depreciation methods </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(651</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(675</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_ecustom--DeferredTaxLiabilitiesRightOfUseAsset_i01NI_pn3n3_di_maDITLzBv6_zFFCLxg6sG14" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Right of use asset </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(313</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(439</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--DeferredTaxLiabilitiesDeferredStateTax_i01NI_pn3n3_di_maDITLzBv6_zlZU0GZfuZ72" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Deferred state tax </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(61</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(78</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--DeferredTaxAssetsUnrealizedGainOnAvailableforSaleSecuritiesGross_i01NI_pn3n3_di_maDITLzBv6_zOkKOXUHCqNd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Unrealized gains </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(995</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(541</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pn3n3_di_mtDITLzBv6_msDTALNzok3_zNHeSVPFHqU2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Total gross deferred tax liabilities </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,020</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,733</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--DeferredTaxAssetLiabilitiesNet_i01TI_pn3n3_mtDTALNzok3_zkYK8rNiCome" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9.35pt; padding-left: 18.7pt">Net deferred tax assets </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,415</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zp1Ng7hFyNz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Realization of our deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. As of June 30, 2025, our deferred tax asset valuation allowance primarily consists of state net operating loss carryforwards for states in which we have filed a final return. For the fiscal years ended June 30, 2025 and 2024, we recorded a net decrease to our valuation allowance of $<span id="xdx_90C_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20240701__20250630_pp0p" title="Increase (Decrease) in deferred tax asset valuation allowance">0</span> and $<span id="xdx_90E_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20230701__20240630_pp0p" title="Increase (Decrease) in deferred tax asset valuation allowance">1,000</span>, respectively, on the basis of management’s reassessment of the amount of our deferred tax assets that are more likely than not to be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June 30, 2025, we did not have any net operating losses for federal and state income tax purposes for state jurisdictions in which we currently operate. We have no federal or state research and development and alternative minimum tax credit carry forwards at June 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June 30, 2025, we have accrued $<span id="xdx_907_ecustom--UnrecognizedTaxBenefit_c20250630_pp0p" title="Unrecognized tax benefits">159,000</span> of unrecognized tax benefits related to federal and state income tax matters that would reduce our income tax expense if recognized. If we are eventually able to recognize our uncertain tax positions, our effective tax rate would be reduced. Any adjustment to our uncertain tax positions would result in a cash outlay.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Information with respect to our accrual for unrecognized tax benefits is as follows (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_pn3n3_zk4SFS1tkM26" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 3)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8BC_zMLxSScLlLO8" style="display: none">Schedule of accrual unrecognized tax benefits</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unrecognized tax benefits:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Beginning balance </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_902_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20240701__20250630_z67LWPxkotyd" title="Beginning balance">262</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_906_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20230701__20240630_zVC2IRh4Xkq5" title="Beginning balance">345</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">    Additions based on federal tax positions related to the current year </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsOnFederalTax_pn3n3_c20240701__20250630_zZr7J2gP1FR7" title="Additions based on federal tax positions related to the current year">11</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsOnFederalTax_pn3n3_c20230701__20240630_ztxmDJUrJU27" title="Additions based on federal tax positions related to the current year">15</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">    Additions based on state tax positions related to the current year </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsUponStateTax_pn3n3_c20240701__20250630_zabnzBcrOzHe" title="Additions based on state tax positions related to the current year">11</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsUponStateTax_pn3n3_c20230701__20240630_z6d3quoHY58k" title="Additions based on state tax positions related to the current year">17</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">    Additions (reductions) for tax positions of prior years </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPosition_pn3n3_c20240701__20250630_zGDeq64Kvmm3" title="Additions for tax positions of prior years">(10</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPosition_pn3n3_c20230701__20240630_zAJjtK37yNXf" title="Additions for tax positions of prior years">3</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">    Reductions due to lapses in statutes of limitation </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_iN_pn3n3_di_c20240701__20250630_zHk0oDXGlpk9" title="Reductions due to lapses in statutes of limitation">(115</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_iN_pn3n3_di_c20230701__20240630_zih0ZEIwICD2" title="Reductions due to lapses in statutes of limitation">(118</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Ending balance </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20240701__20250630_zoB9mgfsYIRe" title="Ending balance">159</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20230701__20240630_zGrBYXqU2hQb" title="Ending balance">262</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zZwUDouDcLW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although it is reasonably possible that certain unrecognized tax benefits may increase or decrease within the next twelve months due to tax examinations, settlement activities, expirations of statute of limitations, or the impact on recognition and measurement considerations related to the results of published tax cases or other similar activities, we do not anticipate any significant changes to unrecognized tax benefits over the next twelve months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense when applicable. As of June 30, 2025, $<span id="xdx_90B_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20240701__20250630_pp0p" title="Interest or penalties">28,000</span> of interest applicable to our unrecognized tax benefits has been accrued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to U.S. federal income tax, as well as income tax of California and Colorado. We are currently open to audit under the statute of limitations by the Internal Revenue Service for the years ended June 30, 2022, and later.  However, because of our prior net operating losses and research credit carryovers, our tax years from June 30, 2020, are open to audit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the One Big Beautiful Bill Act of 2025, or the 2025 Act, enacted on July 4, 2025, makes changes to U.S. corporate income taxes including reinstating the option to claim 100% accelerated depreciation deductions on qualified property, with retroactive application beginning January 20, 2025 and immediate expensing of research and development costs, with retroactive application beginning January 1, 2025. We are currently in the process of evaluating the impact of adoption of the 2025 Act to our financial position and results of operations for income tax purposes for the fiscal year ending June 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_pn3n3_zxghW32Ok1H3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"><span style="font-size: 8pt"> <span id="xdx_8B1_zq56ax5j2lci" style="display: none">Schedule of provision for income taxes</span></span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_496_20240701__20250630_zK9Xb8WVAiIc" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_49F_20230701__20240630_ziCV89Jj0ywg" style="font-size: 8pt; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-size: 8pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zmvMxraENCB" style="vertical-align: bottom"> <td>Current:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pn3n3_zCDcNEsySwUi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; width: 66%">Federal </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,114</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,493</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pn3n3_zMVO9vTZDHca" style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">State </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">826</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">577</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zuovlBaQ3iA3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pn3n3_zyjiU2OnYnCh" style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">Federal </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,210</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pn3n3_zAfUKAfbom4d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; padding-bottom: 1pt">State </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">64</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(353</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_zHpUpxejd2Zi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,080</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">507</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2114000 1493000 826000 577000 76000 -1210000 64000 -353000 3080000 507000 <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_pn3n3_zTSES4Oce9zk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8B4_z51gjeB0vsJ8" style="display: none">Schedule of reconciliation federal statutory income tax rates</span></span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Percent Pretax Income</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Percent Pretax Income</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Income before income taxes </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630_z8DHLY7mgjug" title="Income before income taxes">12,058</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_908_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestTaxRate_pid_dp_c20240701__20250630_zM8h5cayPcOd" title="Income before income taxes, Percent pretax income">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630_zcGnV7RtIw96" title="Income before income taxes">2,634</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_903_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestTaxRate_pid_dp_c20230701__20240630_z9pkAoaoTNvk" title="Income before income taxes, Percent pretax income">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Computed “expected” income tax expense on income before income taxes </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRates_pn3n3_c20240701__20250630_zDCvgcefc8sa" title="Computed &quot;expected&quot; income tax expense on income before income taxes">2,532</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_pid_dp_c20240701__20250630_z2WCacRfedz7" title="Computed &quot;expected&quot; income tax expense on income before income taxes, Percent pretax income">21</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRates_pn3n3_c20230701__20240630_zRvz47yzm6ca" title="Computed &quot;expected&quot; income tax expense on income before income taxes">553</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_pid_dp_c20230701__20240630_zU1akSqlSH1j" title="Computed &quot;expected&quot; income tax expense on income before income taxes, Percent pretax income">21</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">State tax, net of federal benefit </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_c20240701__20250630_zylegQF48G11" title="State tax, net of federal benefit">964</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_c20240701__20250630_zYXDG6tfEGR8" title="State tax, net of federal benefit, Percent pretax income">8</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_c20230701__20240630_z4hTzAd8sfY1" title="State tax, net of federal benefit">212</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_c20230701__20240630_zWCAyW6lYFe2" title="State tax, net of federal benefit, Percent pretax income">8</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Tax incentives </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--IncomeTaxReconciliationTaxExemptIncome_pn3n3_c20240701__20250630_zNrrP2yLTTb6" title="Tax incentives">(149</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxExemptIncome_pid_dp_c20240701__20250630_zGkrpyWdsXG3" title="Tax incentives, Percent pretax income">(1</span></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--IncomeTaxReconciliationTaxExemptIncome_pn3n3_c20230701__20240630_z6lfzu3UpKZ8" title="Tax incentives">(214</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxExemptIncome_pid_dp_c20230701__20240630_zNkHwvgShXFd" title="Tax incentives, Percent pretax income">(8</span></td><td style="text-align: left">%)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Uncertain tax position </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--UncertainTaxPositions_pn3n3_c20240701__20250630_zCoM4fiB2oQ9" title="Uncertain tax position">(116</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--UncertainTaxPosition_pid_dp_c20240701__20250630_z9oVFrGXlz35" title="Uncertain tax position, Percent pretax income">(1</span></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--UncertainTaxPositions_pn3n3_c20230701__20240630_zEdHpMspuNoh" title="Uncertain tax position">(88</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--UncertainTaxPosition_pid_dp_c20230701__20240630_ztMufoyPcgRh" title="Uncertain tax position, Percent pretax income">(3</span></td><td style="text-align: left">%)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Stock based compensation </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--IncomeTaxReconciliationShareBasedCompensation_pn3n3_c20240701__20250630_zfrhXBAxwHUe" title="Share based compensation">(164</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_c20240701__20250630_z5jviWrXNTRj" title="Share based compensation, Percent pretax income">(1</span></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--IncomeTaxReconciliationShareBasedCompensation_pn3n3_c20230701__20240630_zBN4p3fmRQe8" title="Share based compensation">2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp0_c20230701__20240630_zLkooWHMukja" title="Share based compensation, Percent pretax income">—</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Other </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_pn3n3_c20240701__20250630_z6g5SlNDlzui" title="Other">13</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_pid_dp0_c20240701__20250630_zJPGTl6pBk3g" title="Other, Percent pretax income">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--IncomeTaxReconciliationOtherReconcilingItems_pn3n3_c20230701__20240630_zHfLHy88Qgte" title="Other">42</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_pid_dp_c20230701__20240630_zySmhsMArrdg" title="Other, Percent pretax income">1</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt">Income tax expense </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20240701__20250630_zRvTIcfSEOLc" title="Income tax expense">3,080</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20240701__20250630_z91Gy2x0v39k" title="Income tax expense, Percent pretax income">26</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20230701__20240630_zp1pedpZUYNc" title="Income tax expense">507</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_c20230701__20240630_zd8Od3j0vgul" title="Income tax expense, Percent pretax income">19</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 12058000 1 2634000 1 2532000 0.21 553000 0.21 964000 0.08 212000 0.08 -149000 -0.01 -214000 -0.08 -116000 -0.01 -88000 -0.03 -164000 -0.01 2000 0 13000 0 42000 0.01 3080000 0.26 507000 0.19 <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_zA80XnUfjjt3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span id="xdx_8BF_z1LYqscVVPh6" style="display: none">Schedule of deferred income tax assets and liabilities</span><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_499_20250630_zMw9FZBRzVp8" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" id="xdx_499_20240630_zWm47pNnsUU2" style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zql4M2diEaE1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pn3n3_maDTAGzZtz_znlqBBYoXvJ7" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Federal and state NOL carryforward </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">23</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">23</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--DeferredTaxAssetsResearchAndOtherCredits_i01I_pn3n3_maDTAGzZtz_zZiRhYBeeqfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Research and other credits </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_i01I_pn3n3_maDTAGzZtz_z1xh4DEWD5y3" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9.35pt; padding-left: 18.7pt">Reserves </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">170</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">146</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_i01I_pn3n3_maDTAGzZtz_z99JHtShWMF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9.35pt; padding-left: 18.7pt">Accruals </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">436</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">309</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_pn3n3_maDTAGzZtz_zn5Sig4Wp1Qe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Stock based compensation </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,096</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,008</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--Section174Capitalization_i01I_pn3n3_maDTAGzZtz_zMMyUuAg72Ph" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Section 174 capitalization </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">756</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">738</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--DeferredTaxAssetLeaseLiability_i01I_pn3n3_maDTAGzZtz_zhksm673Vafa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Lease liability </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">353</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">488</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsInventory_i01I_pn3n3_maDTAGzZtz_zd5ZTByuNRN8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9.35pt; padding-left: 18.7pt">Inventory </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">614</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">596</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsOther_i01I_pn3n3_maDTAGzZtz_zCBZtBYFxDej" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Other </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_i01TI_pn3n3_mtDTAGzZtz_maDTANz1YX_zB5p1id9V4K6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Total gross deferred tax assets </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,525</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,378</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pn3n3_di_msDTANz1YX_z4k2Ef3AljFh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Less: valuation allowance </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(90</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(90</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_i01TI_pn3n3_mtDTANz1YX_maDTALNzok3_zlzY3YNRFJf8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9.35pt; padding-left: 18.7pt">Total deferred tax assets </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,435</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,288</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_z7rmPPrTNEtb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pn3n3_di_maDITLzBv6_zjdDl88MWhUd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Property and equipment, principally due to differing depreciation methods </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(651</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(675</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_ecustom--DeferredTaxLiabilitiesRightOfUseAsset_i01NI_pn3n3_di_maDITLzBv6_zFFCLxg6sG14" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Right of use asset </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(313</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(439</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--DeferredTaxLiabilitiesDeferredStateTax_i01NI_pn3n3_di_maDITLzBv6_zlZU0GZfuZ72" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Deferred state tax </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(61</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(78</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--DeferredTaxAssetsUnrealizedGainOnAvailableforSaleSecuritiesGross_i01NI_pn3n3_di_maDITLzBv6_zOkKOXUHCqNd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Unrealized gains </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(995</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(541</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pn3n3_di_mtDITLzBv6_msDTALNzok3_zNHeSVPFHqU2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Total gross deferred tax liabilities </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,020</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,733</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--DeferredTaxAssetLiabilitiesNet_i01TI_pn3n3_mtDTALNzok3_zkYK8rNiCome" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9.35pt; padding-left: 18.7pt">Net deferred tax assets </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,415</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 23000 23000 65000 65000 170000 146000 436000 309000 1096000 1008000 756000 738000 353000 488000 614000 596000 12000 5000 3525000 3378000 90000 90000 3435000 3288000 651000 675000 313000 439000 61000 78000 995000 541000 2020000 1733000 1415000 1555000 0 1000 159000 <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_pn3n3_zk4SFS1tkM26" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 3)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8BC_zMLxSScLlLO8" style="display: none">Schedule of accrual unrecognized tax benefits</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unrecognized tax benefits:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; text-indent: -9.35pt; padding-left: 18.7pt">Beginning balance </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_902_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20240701__20250630_z67LWPxkotyd" title="Beginning balance">262</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_906_eus-gaap--UnrecognizedTaxBenefits_iS_pn3n3_c20230701__20240630_zVC2IRh4Xkq5" title="Beginning balance">345</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">    Additions based on federal tax positions related to the current year </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsOnFederalTax_pn3n3_c20240701__20250630_zZr7J2gP1FR7" title="Additions based on federal tax positions related to the current year">11</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsOnFederalTax_pn3n3_c20230701__20240630_ztxmDJUrJU27" title="Additions based on federal tax positions related to the current year">15</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">    Additions based on state tax positions related to the current year </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsUponStateTax_pn3n3_c20240701__20250630_zabnzBcrOzHe" title="Additions based on state tax positions related to the current year">11</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositionsUponStateTax_pn3n3_c20230701__20240630_z6d3quoHY58k" title="Additions based on state tax positions related to the current year">17</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">    Additions (reductions) for tax positions of prior years </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPosition_pn3n3_c20240701__20250630_zGDeq64Kvmm3" title="Additions for tax positions of prior years">(10</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPosition_pn3n3_c20230701__20240630_zAJjtK37yNXf" title="Additions for tax positions of prior years">3</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">    Reductions due to lapses in statutes of limitation </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_iN_pn3n3_di_c20240701__20250630_zHk0oDXGlpk9" title="Reductions due to lapses in statutes of limitation">(115</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_iN_pn3n3_di_c20230701__20240630_zih0ZEIwICD2" title="Reductions due to lapses in statutes of limitation">(118</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -9.35pt; padding-left: 18.7pt">Ending balance </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20240701__20250630_zoB9mgfsYIRe" title="Ending balance">159</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefits_iE_pn3n3_c20230701__20240630_zGrBYXqU2hQb" title="Ending balance">262</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> 262000 345000 11000 15000 11000 17000 -10000 3000 115000 118000 159000 262000 28000 <p id="xdx_807_eus-gaap--DebtDisclosureTextBlock_zOAR4Lm1zOAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>8.        <span id="xdx_828_zQTcqum4upWf">NOTES PAYABLE AND FINANCING TRANSACTIONS </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>UMB Bank/Minnesota Bank &amp; Trust </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15pt; text-align: justify; text-indent: 40.35pt"><span style="letter-spacing: 0pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15pt; text-align: justify; text-indent: 40.35pt"><span style="letter-spacing: 0pt">As previously disclosed, we have several outstanding term loans as well as a revolving loan (the “Amended Revolving Loan”) under our Amended and Restated Credit Agreement with MBT (as subsequently amended, the “Amended Credit Agreement”). On</span> July 31, 2024 (the “Fourth Amendment Date”), we entered into Amendment No. 4 to the Amended Credit Agreement (the “Fourth Amendment”) which, (i) provided for a new term loan, Term Loan C, in the amount of $<span id="xdx_902_eus-gaap--DebtInstrumentRepurchaseAmount_iI_pn5n6_c20240731__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--LongtermDebtTypeAxis__custom--TermLoanCMember_zAbO4N6qrLW7" title="Loan amount">5.0</span> million, (ii) used the proceeds from Term Loan C to repay the entire $<span id="xdx_903_eus-gaap--DebtInstrumentRepurchasedFaceAmount_iI_pn5n6_c20240731__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--LongtermDebtTypeAxis__custom--TermLoanCMember_z9TbehNotzpa" title="Loan repaid amount">3.0</span> million balance that was outstanding on the Fourth Amendment Date under the Amended Revolving Loan, and (iii) terminated our Supplemental Loan, under which no amounts had been drawn. Loan origination fees in the amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFeeAmount_iI_pp0d_c20240731__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--LongtermDebtTypeAxis__custom--TermLoanCMember_z04tCxlgU4P" title="Loan origination fee">10,000</span> were paid to MBT in conjunction with Term Loan C. On December 23, 2024, we entered into Amendment No. 5 to the Amended Credit Agreement (the “Fifth Amendment”), which extended the maturity date of the Amended Revolving Loan from December 29, 2025, to December 29, 2026. On January 31, 2025, UMB Bank acquired MBT. On April 8, 2025, we entered into Amendment No. 6 to the Amended Credit Agreement (the “Sixth Amendment”), which among other things, increased the revolving line of credit under the Amended Revolving Loan from $7,000,000 to $<span id="xdx_907_eus-gaap--DebtInstrumentRepurchaseAmount_iI_pp0d_c20250408__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--LongtermDebtTypeAxis__custom--TermLoanCMember_zGxq4MbZlFsh" title="Loan amount">11,000,000</span>. Loan origination fees in the amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFeeAmount_iI_pp0d_c20250408__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--LongtermDebtTypeAxis__custom--TermLoanCMember_zMww5JIxjt3h" title="Loan origination fee">8,000</span> were paid to MBT in connection with the Sixth Amendment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15pt; text-align: justify; text-indent: 40.35pt">The balance on our outstanding loans at June 30, 2025 and June 30, 2024 (in thousands) is as follows (exclusive of unamortized loan fees):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15pt; text-align: justify; text-indent: 40.35pt"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfOutstandingLoansTableTextBlock_pn3n3_zBmHSgnDiL" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE AND FINANCING TRANSACTIONS (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8BA_zI5DAUKVX9u4" style="display: none">Schedule of outstanding loans</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, <br/>2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, <br/>2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Notes Payable:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; width: 66%; text-align: left">Term Loan A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90A_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanAMember_z6ar2CkuECDc" title="Total notes payable">2,795</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90E_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanAMember_zelfUwIzl6Z8" title="Total notes payable">3,834</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Term Loan B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanBMember_z1GZyLgCY4re" title="Total notes payable">416</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanBMember_zOIeLJOaqxl3" title="Total notes payable">571</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Term Loan C </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanCMember_zhu2tZt5L7C1" title="Total notes payable">4,167</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanCMember_zerAEGy7qqv8" title="Total notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1083">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Property Loan </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--PropertyLoanMember_z3lxdtGAcskf" title="Total notes payable">4,347</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--PropertyLoanMember_zFQmuhgp9mS7" title="Total notes payable">4,551</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left; padding-bottom: 1pt">Amended Revolving Loan </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--AmendedRevolvingLoanMember_zSqsjIZjzIR" title="Total notes payable">3,706</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--AmendedRevolvingLoanMember_zOKAB48MzSI1" title="Total notes payable">3,000</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total notes payable </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--NotesPayable_iI_pn3n3_c20250630_zscyQINYZzha" title="Total notes payable">15,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--NotesPayable_iI_pn3n3_c20240630_zwA6PA1BSQfg" title="Total notes payable">11,956</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zh55Q2DP4BZd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15pt; text-align: justify; text-indent: 40.35pt"> <span style="letter-spacing: 0pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Term Loan A and B both bear interest at a fixed rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_c20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--DebtInstrumentAxis__custom--TermLoanAandBMember_pd" title="Interest rate">3.84%</span> per annum, the Property Loan bears interest at a fixed rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_c20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--DebtInstrumentAxis__custom--PropertyLoanMember_pd" title="Interest rate">3.55%</span> per annum and Term Note C bears interest at an annual rate equal to the greater of (a) <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_c20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--DebtInstrumentAxis__custom--TermLoanCMember_pd" title="Interest rate">5%</span>, or (b) the </span>SOFR one-month rate plus 2.5% (the “Adjusted Term SOFR Rate”). <span style="letter-spacing: 0pt">The Amended Revolving Loan bears interest at an annual rate equal to the greater of (a) <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_c20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--DebtInstrumentAxis__custom--AmendedRevolvingLoanMember_pd" title="Interest rate">4%</span>, or (b) t</span>he Adjusted Term SOFR Rate. Term Loan A and Term Loan B are both fully amortizing and mature on <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_c20240701__20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--DebtInstrumentAxis__custom--TermLoanAandBMember_zuq3Iih46SP5" title="Maturity date">November 1, 2027</span>, Term Loan C is fully amortizing and matures on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_c20240701__20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--DebtInstrumentAxis__custom--TermLoanCMember_zYnGt9LvdQM1" title="Maturity date">August 1, 2029</span>, the Property Loan matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20240701__20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--DebtInstrumentAxis__custom--PropertyLoanMember_zNBoIvH70qL1" title="Maturity date">November 1, 2030</span>, at which time a balloon payment in the principal amount of $<span id="xdx_909_ecustom--BalloonPayment_pn5n6_c20240701__20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--DebtInstrumentAxis__custom--PropertyLoanMember_zl9aj8Q9PbKc" title="Balloon payment">3.1</span> million is due (plus any accrued and unpaid interest), and the Amended Revolving Loan matures on <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_c20240701__20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember__us-gaap--DebtInstrumentAxis__custom--AmendedRevolvingLoanMember_zp7hdEvl8Ssk" title="Maturity date">December 29, 2026</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Any payment on Term Loan A, Term Loan B, Term Loan C, the Property Loan, or Amended Revolving Loan (collectively, the “Loans”) not made within seven days after the due date is subject to a late payment fee equal to <span id="xdx_902_ecustom--PercentageOfLatePaymentFee_c20240701__20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember_pd" title="Percentage of late payment fee">5%</span> of the overdue amount. Upon the occurrence and during the continuance of an event of default under any of the Loans, the interest rate of all Loans will be increased by <span id="xdx_90F_ecustom--IncreasedPercentageOfDefaultLatePayment_c20240701__20250630__srt--CounterpartyNameAxis__custom--MinnesotaBankAndTrustMember_pd" title="Increased percentage of default late payment">3%</span> and MBT may, at its option, declare all of the Loans immediately due and payable in full. The Loans are secured by substantially all of the Company’s assets pursuant to a Security Agreement entered into between the Company and MBT. The Property Loan is secured by the Franklin Property pursuant to a Deed of Trust with Assignment of Leases and Rents, Security Agreement and Fixture Filing in favor of MBT and by an assignment of Leases and Rents by PDEX Franklin in favor of MBT (collectively, the “Property Loan Security Agreements”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">The Amended Credit Agreement, Security Agreement, Property Loan Security Agreements, Term Loan A, Term Loan B, Term Loan C, Property Loan, and Amended Revolving Loan contain representations and warranties, affirmative, negative and financial covenants, and events of default that are customary for loans of this type. We believe that we are in compliance with all of our debt covenants as of June 30, 2025, but there can be no assurance that we will remain in compliance for the duration of the term of the Loans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="letter-spacing: 0pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Scheduled principal maturities of the Loans, assuming repayment of the Amended Revolving Loan in full in fiscal 2026 and exclusive of unamortized loan origination fees in the amount of $37,000, for future fiscal years ending June 30 are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_pn3n3_z1nQJaHRHIY8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - NOTES PAYABLE AND FINANCING TRANSACTIONS (Details 1)"> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; font-weight: bold; text-align: left"> <span id="xdx_8B3_zUsRXrtb8vS4" style="display: none">Schedule of maturities of term loan for future fiscal years</span></td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1pt; vertical-align: top; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Term Loan Principal Payments</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">Fiscal Year:</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; width: 75%; text-align: left">2026</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><span id="xdx_906_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_c20250630_zAknfo1d2xPi" title="2026">6,158</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; text-align: left">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_c20250630_zC52mlIW41c2" title="2027">2,508</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; text-align: left">2028</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pn3n3_c20250630_zdTGyvppRGWk" title="2028">1,908</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; text-align: left">2029</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_pn3n3_c20250630_zytc8lfzhOa2" title="2029">1,235</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; text-align: left">2030</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_pn3n3_c20250630_zSKY4Nx5sxTb" title="2030">410</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; padding-bottom: 1pt; vertical-align: top; text-align: left">Thereafter </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pn3n3_c20250630_zjrSdZ3yVXj7" title="Thereafter">3,212</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left">Total principal payments </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--LongTermDebt_iI_pn3n3_c20250630_zsPFENo1p9qf" title="Total principal payments">15,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z2EXzWgYPGxc" style="font: 10pt inherit,serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt inherit,serif; margin: 0pt 0; text-align: justify"></p> 5000000.0 3000000.0 10000 11000000 8000 <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfOutstandingLoansTableTextBlock_pn3n3_zBmHSgnDiL" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE AND FINANCING TRANSACTIONS (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8BA_zI5DAUKVX9u4" style="display: none">Schedule of outstanding loans</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, <br/>2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, <br/>2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Notes Payable:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; width: 66%; text-align: left">Term Loan A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90A_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanAMember_z6ar2CkuECDc" title="Total notes payable">2,795</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span id="xdx_90E_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanAMember_zelfUwIzl6Z8" title="Total notes payable">3,834</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Term Loan B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanBMember_z1GZyLgCY4re" title="Total notes payable">416</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanBMember_zOIeLJOaqxl3" title="Total notes payable">571</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left">Term Loan C </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanCMember_zhu2tZt5L7C1" title="Total notes payable">4,167</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--TermLoanCMember_zerAEGy7qqv8" title="Total notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1083">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 10pt; text-align: left">Property Loan </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--PropertyLoanMember_z3lxdtGAcskf" title="Total notes payable">4,347</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--PropertyLoanMember_zFQmuhgp9mS7" title="Total notes payable">4,551</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; text-align: left; padding-bottom: 1pt">Amended Revolving Loan </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--NotesPayable_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--AmendedRevolvingLoanMember_zSqsjIZjzIR" title="Total notes payable">3,706</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--ShortTermDebtTypeAxis__custom--AmendedRevolvingLoanMember_zOKAB48MzSI1" title="Total notes payable">3,000</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total notes payable </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--NotesPayable_iI_pn3n3_c20250630_zscyQINYZzha" title="Total notes payable">15,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--NotesPayable_iI_pn3n3_c20240630_zwA6PA1BSQfg" title="Total notes payable">11,956</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2795000 3834000 416000 571000 4167000 4347000 4551000 3706000 3000000 15431000 11956000 0.0384 0.0355 0.05 0.04 2027-11-01 2029-08-01 2030-11-01 3100000 2026-12-29 0.05 0.03 <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_pn3n3_z1nQJaHRHIY8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - NOTES PAYABLE AND FINANCING TRANSACTIONS (Details 1)"> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; font-weight: bold; text-align: left"> <span id="xdx_8B3_zUsRXrtb8vS4" style="display: none">Schedule of maturities of term loan for future fiscal years</span></td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1pt; vertical-align: top; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Term Loan Principal Payments</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">Fiscal Year:</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; width: 1%; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; width: 75%; text-align: left">2026</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><span id="xdx_906_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_c20250630_zAknfo1d2xPi" title="2026">6,158</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; text-align: left">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_c20250630_zC52mlIW41c2" title="2027">2,508</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; text-align: left">2028</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pn3n3_c20250630_zdTGyvppRGWk" title="2028">1,908</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; text-align: left">2029</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_pn3n3_c20250630_zytc8lfzhOa2" title="2029">1,235</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; vertical-align: top; text-align: left">2030</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_pn3n3_c20250630_zSKY4Nx5sxTb" title="2030">410</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: top; text-align: left"> </td><td style="text-indent: 10pt; padding-bottom: 1pt; vertical-align: top; text-align: left">Thereafter </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pn3n3_c20250630_zjrSdZ3yVXj7" title="Thereafter">3,212</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left">Total principal payments </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--LongTermDebt_iI_pn3n3_c20250630_zsPFENo1p9qf" title="Total principal payments">15,431</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6158000 2508000 1908000 1235000 410000 3212000 15431000 <p id="xdx_80B_eus-gaap--LesseeOperatingLeasesTextBlock_zkARfqDL8hH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: inherit,serif"><b>9.       </b></span><b> <span id="xdx_827_zp6cE1XgPr26">LEASES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operating lease ROU asset and long-term liability are presented separately on our consolidated balance sheet. The current portion of our operating lease liability, exclusive of imputed interest, as of June 30, 2025, in the amount of $<span id="xdx_90B_ecustom--OperatingLeaseLiabilityCurrents_iI_pn3p0_c20250630_z1qRfAdZZ11" title="Operating lease liability current portion">498,000</span>, is presented within accrued expenses on the consolidated balance sheet. As of June 30, 2025, the maturity of our lease liability is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfFutureMinimumRentalPaymentForOperatingLeasesTableTextBlock_pn3n3_zBV8ny6phela" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - LEASES (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"> <span id="xdx_8B1_z1I9rolqhIVd" style="display: none">Schedule of maturities of lease liabilities</span></td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1pt; vertical-align: top; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Operating Lease</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: left">Fiscal Year:</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 1%; text-align: left"> </td><td style="width: 75%; text-align: left">2026</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><span id="xdx_905_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20250630_zVb97QjBGICi" title="2026">551</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: left">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20250630_zyTRM41hbAld" title="2027">567</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: left">2028</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20250630_zTrLvwoPghNi" title="2028">143</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: left">       Total lease payments </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20250630_zxD7CdIbx4U2" title="Total lease payments">1,261</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: left">       Less imputed interest: </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_c20250630_zSk77WbYm2F4" title="Less imputed interest:">(78</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: left">Total </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_ecustom--OperatingLeaseLiabilities_iI_pn3n3_c20250630_z1RF9gs5J7bb" title="Total">1,183</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June 30, 2025 and 2024, our operating lease has a remaining lease term of <span id="xdx_903_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20250630_zcOlsMEODsHg" title="Operating lease has a remaining lease term">2.25</span> years and <span id="xdx_903_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20240630_zchS1hZjPHe8" title="Operating lease has a remaining lease term">3.25</span> years, respectively, and an imputed interest rate of <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_c20250630_pd" title="Interest rate"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_c20240630_pd" title="Interest rate">5.3%</span></span>. Our lease agreement does not provide an implicit rate and, as a result, we used our estimated incremental borrowing rate at the time we adopted ASC 842 to determine the present value of future lease payments. Cash paid for amounts included in the lease liability for the fiscal years ended June 30, 2025 and 2024 was $<span id="xdx_90D_eus-gaap--OperatingLeasePayments_pp0d_c20240701__20250630_zVA4k5Yqqna5" title="Cash paid lease liability">535,000</span> and $<span id="xdx_901_eus-gaap--OperatingLeasePayments_pp0d_c20230701__20240630_zpNjBngS4mee" title="Cash paid lease liability">519,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 498000 <table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfFutureMinimumRentalPaymentForOperatingLeasesTableTextBlock_pn3n3_zBV8ny6phela" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - LEASES (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"> <span id="xdx_8B1_z1I9rolqhIVd" style="display: none">Schedule of maturities of lease liabilities</span></td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1pt; vertical-align: top; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Operating Lease</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: left">Fiscal Year:</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 1%; text-align: left"> </td><td style="width: 75%; text-align: left">2026</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><span id="xdx_905_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20250630_zVb97QjBGICi" title="2026">551</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: left">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20250630_zyTRM41hbAld" title="2027">567</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: left">2028</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20250630_zTrLvwoPghNi" title="2028">143</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: left">       Total lease payments </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_c20250630_zxD7CdIbx4U2" title="Total lease payments">1,261</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: left">       Less imputed interest: </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_c20250630_zSk77WbYm2F4" title="Less imputed interest:">(78</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: left">Total </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_ecustom--OperatingLeaseLiabilities_iI_pn3n3_c20250630_z1RF9gs5J7bb" title="Total">1,183</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 551000 567000 143000 1261000 78000 1183000 P2Y3M P3Y3M 0.053 0.053 535000 519000 <p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zOe1P4teS6zh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.        <span id="xdx_821_zfCvmGaGZNYc">COMMITMENTS AND CONTINGENCIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Leases</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We lease our office, production, and warehouse facility in Irvine, California (our “corporate office”) under an agreement that expires in September 2027. Our corporate office lease requires us to pay insurance, taxes, and other expenses related to the leased space.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Rent expense in fiscal 2025 and 2024 was $<span id="xdx_90D_ecustom--LeaseAndRentalExpenses_c20240701__20250630_pp0p" title="Rent expense">609,000</span> and $<span id="xdx_90F_ecustom--LeaseAndRentalExpenses_c20230701__20240630_pp0p" title="Rent expense">559,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, beginning in fiscal 2025 we began renting on a month-to-month basis some parking spaces at a neighboring location near our Franklin Property. In fiscal 2025, we incurred rent expense in the amount of $<span id="xdx_900_eus-gaap--OperatingLeasesRentExpenseNet_c20240701__20250630_z0jKzNl9TGSi" title="Rent expense">23,000</span> for parking.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Arrangements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i><span style="text-decoration: underline">Retirement Savings 401(k) Plan</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Pro-Dex, Inc. Retirement Savings 401(k) Plan (the “401(k) Plan”) is a defined contribution plan we administer that covers substantially all our employees and is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended. Employees are eligible to participate in the 401(k) Plan when they have attained 19 years of age and then can enter into the 401(k) Plan on the first of the month following 60 days of service. Participants are eligible to receive non-discretionary matching contributions by the Company equal to <span id="xdx_90D_eus-gaap--DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_c20240701__20250630__us-gaap--PlanNameAxis__custom--RetirementSavings401kPlanMember_pd" title="Percentage of matching contributions">50%</span> of their contributions up to <span id="xdx_904_ecustom--DefinedContributionPlanEmployeeContributionPercentageOfEmployeeCompensationMaximum_c20240701__20250630__us-gaap--PlanNameAxis__custom--RetirementSavings401kPlanMember_pd" title="Percentage of maximum employee contributions">5%</span> of eligible compensation. For the fiscal years ended June 30, 2025 and 2024, we recognized compensation expense amounting to $<span id="xdx_905_eus-gaap--DefinedContributionPlanCostRecognized_c20240701__20250630__us-gaap--PlanNameAxis__custom--RetirementSavings401kPlanMember_pp0p" title="Compensation expense">259,000</span> and $<span id="xdx_907_eus-gaap--DefinedContributionPlanCostRecognized_c20230701__20240630__us-gaap--PlanNameAxis__custom--RetirementSavings401kPlanMember_pp0p" title="Compensation expense">188,000</span>, respectively, in connection with the 401(k) Plan. During our fiscal years ended June 30, 2025 and 2024, we used approximately $<span id="xdx_908_ecustom--ForfeitedMatchContributionsUsedToReduceMatchExpense_c20240701__20250630__us-gaap--PlanNameAxis__custom--RetirementSavings401kPlanMember_pp0p" title="Forfeited match contributions used to reduce match expense">23,000</span> and $<span id="xdx_90E_ecustom--ForfeitedMatchContributionsUsedToReduceMatchExpense_c20230701__20240630__us-gaap--PlanNameAxis__custom--RetirementSavings401kPlanMember_pp0p" title="Forfeited match contributions used to reduce match expense">63,000</span>, respectively, of forfeited match contributions to reduce our match expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Legal Matters</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may be involved in legal proceedings arising either in the ordinary course of our business or incidental to our business. There can be no certainty, however, that we may not ultimately incur liability or that such liability will not be material or adverse.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 609000 559000 23000 0.50 0.05 259000 188000 23000 63000 <p id="xdx_805_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zknx451Px6Ll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>11.        <span id="xdx_82A_zxRSiy3XP0X7">SHARE-BASED COMPENSATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Stock Option Plans</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our 2016 Equity Incentive Plan provides for the award of up to <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20160331__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member_pd" title="Number of shares available to be awarded">1,500,000</span> shares of our common stock in the form of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted shares, restricted stock units, performance awards, and other stock-based awards. As of June 30, 2025, performance awards for <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240701__20250630__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_pd" title="Number of awards granted during period">200,000</span> shares of common stock, non-qualified stock options for <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240701__20250630__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pd" title="Number of awards granted during period">372,000</span> shares of common stock, and <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240701__20250630__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--RestrictedSharesMember_pd" title="Number of awards granted during period">18,000</span> restricted shares of common stock have been granted under the 2016 Equity Incentive Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Performance Awards</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2023, the Compensation Committee reallocated previously forfeited performance awards for <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20231001__20231031__us-gaap--AwardTypeAxis__custom--PreviouslyForfeitedAwardsMember_pd" title="Number of awards granted during period">15,200</span> shares of common stock to other employees. The weighted average fair value of the performance awards reallocated in 2023 which were expected to vest was $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20231001__20231031__us-gaap--AwardTypeAxis__custom--PreviouslyForfeitedAwardsMember_pd" title="Weighted average fair value">10.17</span>, calculated using the weighted average fair market value for each award, using a Monte Carlo simulation. During the fiscal years ended June 30, 2025 and 2024 we recorded share-based compensation expense of $<span id="xdx_901_eus-gaap--AllocatedShareBasedCompensationExpense_pp0d_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zf94OEra45Pi" title="Share-based compensation expense">28,000</span> and $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0d_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_ztEgOaA6KL0d" title="Share-based compensation expense">106,000</span>, respectively, related to outstanding performance awards. On June 30, 2025, there was approximately $28,000 of unrecognized compensation cost related to non-vested performance awards expected to be expensed over the weighted-average period of <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zLVfe88nUwF3" title="Weighted-average remaining contractual life">1.0</span> year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 1, 2024, it was determined by the Compensation Committee that the vesting of performance awards for <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240629__20240702__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_pd" title="Number of awards granted during period">40,000</span> shares of common stock had been achieved. Each participant elected a net issuance to cover their individual withholding taxes and, therefore, we issued participants <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240629__20240702__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_pd" title="Number of shares issued">25,134</span> shares of common stock and paid $<span id="xdx_901_eus-gaap--PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c20240629__20240702__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_pp0p" title="Payroll tax liabilities">273,000</span> of participant-related payroll tax liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a summary of performance awards activity for the fiscal years ended June 30, 2025 and 2024:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_pn3n3_zdkP1yhKaXyk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; text-align: left"> <span id="xdx_8BB_zaUpyIzKxDV8" style="display: none">Schedule of summary of stock option activity</span></td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted-Average <br/>Grant Date Fair Value</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted-Average <br/>Grant Date Fair Value</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 46%; text-align: left">Outstanding at July 1,</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z04LmbfwmFOj" title="Outstanding at beginning of period">80,000</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriodWeightedAverageGrantDateFairValue_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z8FdMFLDRNDl" title="Weighted-Average Grant Date Fair Value, Beginning">7.00</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z42BDUCHTVnc" title="Outstanding at beginning of period">64,800</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriodWeightedAverageGrantDateFairValue_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zhWjMoGE6b4b" title="Weighted-Average Grant Date Fair Value, Beginning">7.03</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> Granted </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zUje2y8p1Tt7" title="Options granted"><span style="-sec-ix-hidden: xdx2ixbrl1225">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z9jPMx5xbzN5" title="Weighted-Average Grant Date Fair Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1227">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zoXBr0v2drlh" title="Options granted">15,200</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zAF5fvYmz1If" title="Weighted-Average Grant Date Fair Value, Granted">10.04</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> Vested </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zIDvAkbRj6g1" title="Options vested">(40,000</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_znRz6NUCCAVj" title="Weighted-Average Grant Date Fair Value, Granted, Vested">7.39</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z3olRcxSrroe" title="Options vested"><span style="-sec-ix-hidden: xdx2ixbrl1237">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zHKMFVSrLUlc" title="Weighted-Average Grant Date Fair Value, Granted, Vested"><span style="-sec-ix-hidden: xdx2ixbrl1239">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"> Forfeited </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zOfThL8ezJR2" title="Options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1241">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zXdAhfAkxhg2" title="Weighted-Average Grant Date Fair Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1243">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zLUHTHjmwnHl" title="Options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1245">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zOcWH2Gn5IT9" title="Weighted-Average Grant Date Fair Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1247">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: left">Outstanding at June 30 </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zVMsblFs3jqi" title="Outstanding at end of period">40,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriod_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zplBNDYexyPg" title="Weighted-Average Grant Date Fair Value, Ending">6.65</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zh4gy3jkPbf3" title="Outstanding at end of period">80,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriod_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zvOr4tKNKvyj" title="Weighted-Average Grant Date Fair Value, Ending">7.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zaFaVjc3pHk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Non-Qualified Stock Options</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2020, the Compensation Committee of our Board of Directors granted non-qualified stock options for <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20201201__20201231__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pd" title="Number of awards granted during period">310,000</span> shares of our common stock to our directors and certain employees under the 2016 Equity Incentive Plan. Whether any stock options vest, and the amount <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_c20201201__20201231__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember" title="Period for award description">that does vest, is tied to the completion of service periods that range from 18 months to 10.5 years at inception and the achievement of our common stock trading at certain pre-determined prices.</span> We recorded compensation expense of $<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_c20240701__20250630_pp0p" title="Share-based compensation expense">416,000</span> and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pp0d_c20230701__20240630_znJyM9EfgPS4" title="Share-based compensation expense">490,000</span> for the fiscal year ended June 30, 2025 and 2024, respectively, related to these options. The weighted average fair value of the stock option awards granted was $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20201201__20201231__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member_zDHpgv0JUf7k" title="Weighted average fair value">16.72</span>, calculated using a Monte Carlo simulation. We recognize forfeitures for our non-qualified stock options as they occur. As of June 30, 2025, there was approximately $1.1 million of unrecognized compensation cost related to these non-vested non-qualified stock options expected to be expensed over the weighted-average period of 44.6 months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2021, the Compensation Committee of our Board of Directors granted non-qualified stock options for <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210227__20210228__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pd" title="Number of awards granted during period">62,000</span> shares of our common stock to our directors and certain employees under the 2016 Equity Incentive Plan. Whether any stock options vest, and the amount that does vest, was tied to the <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_c20210227__20210228__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember" title="Period for award description">completion of service periods that ranged from 4 months to 1.3 years at inception and the achievement of our common stock trading at certain pre-determined prices.</span> Of these stock options, the right to acquire 57,750 shares vested on July 1, 2021, as our common stock met the pre-determined prices set forth in the underlying agreements. We recorded compensation expense of $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20210630__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p" title="Share-based compensation expense">182,000</span> for the fiscal year ended June 30, 2021 related to these options. The weighted average fair value of the stock option awards granted was $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210227__20210228__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pd" title="Weighted average fair value">3.16</span>, calculated using a Monte Carlo simulation. In December 2021, the Compensation Committee of our Board of Directors granted <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20211201__20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pd" title="Number of awards granted during period">5,000</span> previously forfeited non-qualified stock options to another employee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following is a summary of non-qualified stock option activity under the 2016 Equity Incentive Plan for the fiscal year ended June 30, 2025 and 2024:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_pn3n3_z9rjZ6Bjzka6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span id="xdx_8B8_zbTaccVMbsxc" style="display: none">Schedule of summary of stock option activity</span><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weighted-Average <br/>Exercise Price</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weighted-Average <br/>Exercise Price</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%">Outstanding at July 1,</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zj3qDs0TFaNc" title="Outstanding at beginning of period">267,750</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zrsQVA6Wrkd4" title="Outstanding at beginning of period (in dollars per share)">42.11</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zgftS81Nlryc" title="Outstanding at beginning of period">298,937</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z1OjgfIdHTO5" title="Outstanding at beginning of period (in dollars per share)">42.19</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zVYjM4bsGrXb" title="Options granted"><span style="-sec-ix-hidden: xdx2ixbrl1288">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zVi0S7qvyP39" title="Options granted (in dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1290">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zTlULHetITwh" title="Options granted"><span style="-sec-ix-hidden: xdx2ixbrl1292">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z2RQTDwjPwml" title="Options granted (in dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1294">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zp2t8UCwVVce" title="Options exercised">(4,250</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z3Voz7eEHDU2" title="Options exercised (in dollars per share)">27.50</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zO4f8EkVrBy8" title="Options exercised"><span style="-sec-ix-hidden: xdx2ixbrl1300">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zdlA83gyhzZj" title="Options exercised (in dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1302">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Options forfeited/expired </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zbJAZoc6BeC5" title="Options forfeited">(26,250</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zptbJUFg0rFi" title="Options forfeited (in dollars per share)">42.00</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z4sJ93415rx2" title="Options forfeited">(31,187</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zgl1gw2QhwP1" title="Options forfeited (in dollars per share)">42.88</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30 </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z5RegXmOvRgh" title="Outstanding at end of period">237,250</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zkreVAFBMfE4" title="Outstanding at end of period (in dollars per share)">42.38</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zUROQtW39pRk" title="Outstanding at end of period">267,750</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zcTb4MMec7Id" title="Outstanding at end of period (in dollars per share)">42.11</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Stock Options Exercisable at June 30,</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_pid_c20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zTUF963qxI3l" title="Stock Options Exercisable at end of period">79,750</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_pid_c20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zbq34jQUhyma" title="Stock Options Exercisable at end of period (in dollars per share)">32.27</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_pid_c20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zxCNPfwv2N76" title="Stock Options Exercisable at end of period">57,750</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_pid_c20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zYCwrbRJV505" title="Stock Options Exercisable at end of period (in dollars per share)">27.50</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zCgriYaWSdvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $<span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriod_c20240701__20250630_pp0p" title="Option exercise prices, exercised">82,000</span> in fiscal 2025. On June 30, 2025 the options outstanding and exercisable had intrinsic values of $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0d_c20250630_zBFL6WOiBIUk" title="Intrinsic values of options outstanding">299,000</span> and $<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0d_c20250630_zN7UHq3CJBl6" title="Intrinsic values of options exercisable">907,000</span>, respectively. On June 30, 2024 the options outstanding and exercisable had <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0d_do_c20240630_zQPO9SPSIxfc" title="Intrinsic values of options outstanding"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0d_do_c20240630_zYBqUc53EO8d" title="Intrinsic values of options exercisable">no</span></span> intrinsic value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Restricted Shares</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November 2024, the Compensation Committee awarded <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20241101__20241130__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--RestrictedSharesMember_pd" title="Number of awards granted during period">18,000</span> restricted shares of common stock to our directors and certain employees under the 2016 Equity Incentive Plan. <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_c20241101__20241130__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--RestrictedSharesMember" title="Period for award description">The shares vest ratably over five years from the date of grant.</span> The fair value of the restricted shares on the date of grant was $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20241101__20241130__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--RestrictedSharesMember_pp0p" title="Fair value of restricted shares">857,000</span>, based upon the closing price of our common stock on the date of grant. During the fiscal year ended June 30, 2025, we recorded $<span id="xdx_901_eus-gaap--AllocatedShareBasedCompensationExpense_pp0d_c20240701__20250630__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--RestrictedSharesMember_zMT7rbI1GM2e" title="Share-based compensation expense">105,000</span> of compensation expense related to these restricted shares. As of June 30, 2025, there was approximately $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20250630__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--RestrictedSharesMember_pp0p" title="Unrecognized compensation cost">753,000</span> of unrecognized compensation cost related to these restricted shares expected to be expensed over the weighted-average period of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_pp0d_dtM_c20250101__20250630__srt--TitleOfIndividualAxis__custom--DirectorsAndCertainEmployeesMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2016Member__us-gaap--AwardTypeAxis__custom--RestrictedSharesMember_zXJ1K4t6umKf" title="Restricted shares expected to be expensed over the weighted-average period">53</span> months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Employee Stock Purchase Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> In September 2014, our Board approved the establishment of an Employee Stock Purchase Plan (the “ESPP”), which was approved by our shareholders at our 2014 Annual Meeting. The ESPP conforms to the provisions of Section 423 of the Internal Revenue Code, has coterminous <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20140901__20140930__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember" title="Description of employee stock purchase plan">offering and purchase periods of six months, and bases the pricing to purchase shares of our common stock on a formula so as to result in a per share purchase price that approximates a 15% discount from the market price of a share of our common stock at the end of the purchase period.</span> Our Board of Directors also approved that <span id="xdx_90D_eus-gaap--DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_c20140930__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_pd" title="Number of shares reserved for future issuance">704,715</span> shares, be reserved for issuance pursuant to the ESPP. An amendment to the ESPP to extend its term for an additional ten years (through 2035) was approved by our Board in October 2023 and by our shareholders at our 2023 Annual Meeting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the fiscal years ended June 30, 2025 and 2024, shares totaling <span id="xdx_906_eus-gaap--DeferredCompensationArrangementWithIndividualSharesIssued_c20240701__20250630__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_pd" title="Number of shares purchased and allocated to employee">1,593 </span>and <span id="xdx_908_eus-gaap--DeferredCompensationArrangementWithIndividualSharesIssued_c20230701__20240630__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_pd" title="Number of shares purchased and allocated to employee">3,004</span>, respectively, were purchased pursuant to the ESPP and allocated to participating employees based upon their contributions at weighted- average prices of $<span id="xdx_908_eus-gaap--DeferredCompensationArrangementWithIndividualExercisePrice_c20240701__20250630__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_pd" title="Exercise price">26.42</span> and $<span id="xdx_907_eus-gaap--DeferredCompensationArrangementWithIndividualExercisePrice_c20230701__20240630__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_pd" title="Exercise price">16.64</span>, respectively. On a cumulative basis, since the inception of the ESPP, employees have purchased a total of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20240701__20250630__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_pd" title="Number of shares purchased total">37,095</span> shares. During the fiscal years ended June 30, 2025 and 2024, we recorded stock compensation expense in the amount of $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_c20240701__20250630__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_pp0p" title="Share-based compensation expense">7,000</span> and $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_pp0d_c20230701__20240630__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember_z0ydcoOAl5Z2" title="Share-based compensation expense">9,000</span>, respectively, relating to the ESPP.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> 1500000 200000 372000 18000 15200 10.17 28000 106000 P1Y 40000 25134 273000 <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_pn3n3_zdkP1yhKaXyk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; text-align: left"> <span id="xdx_8BB_zaUpyIzKxDV8" style="display: none">Schedule of summary of stock option activity</span></td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted-Average <br/>Grant Date Fair Value</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted-Average <br/>Grant Date Fair Value</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 46%; text-align: left">Outstanding at July 1,</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z04LmbfwmFOj" title="Outstanding at beginning of period">80,000</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriodWeightedAverageGrantDateFairValue_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z8FdMFLDRNDl" title="Weighted-Average Grant Date Fair Value, Beginning">7.00</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z42BDUCHTVnc" title="Outstanding at beginning of period">64,800</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriodWeightedAverageGrantDateFairValue_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zhWjMoGE6b4b" title="Weighted-Average Grant Date Fair Value, Beginning">7.03</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> Granted </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zUje2y8p1Tt7" title="Options granted"><span style="-sec-ix-hidden: xdx2ixbrl1225">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z9jPMx5xbzN5" title="Weighted-Average Grant Date Fair Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1227">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zoXBr0v2drlh" title="Options granted">15,200</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zAF5fvYmz1If" title="Weighted-Average Grant Date Fair Value, Granted">10.04</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> Vested </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zIDvAkbRj6g1" title="Options vested">(40,000</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_znRz6NUCCAVj" title="Weighted-Average Grant Date Fair Value, Granted, Vested">7.39</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_z3olRcxSrroe" title="Options vested"><span style="-sec-ix-hidden: xdx2ixbrl1237">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zHKMFVSrLUlc" title="Weighted-Average Grant Date Fair Value, Granted, Vested"><span style="-sec-ix-hidden: xdx2ixbrl1239">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: left"> Forfeited </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zOfThL8ezJR2" title="Options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1241">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zXdAhfAkxhg2" title="Weighted-Average Grant Date Fair Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1243">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zLUHTHjmwnHl" title="Options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1245">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zOcWH2Gn5IT9" title="Weighted-Average Grant Date Fair Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1247">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: left">Outstanding at June 30 </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zVMsblFs3jqi" title="Outstanding at end of period">40,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriod_pid_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zplBNDYexyPg" title="Weighted-Average Grant Date Fair Value, Ending">6.65</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zh4gy3jkPbf3" title="Outstanding at end of period">80,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriod_pid_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--PerformanceSharesMember_zvOr4tKNKvyj" title="Weighted-Average Grant Date Fair Value, Ending">7.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 80000 7.00 64800 7.03 15200 10.04 40000 7.39 40000 6.65 80000 7.00 310000 that does vest, is tied to the completion of service periods that range from 18 months to 10.5 years at inception and the achievement of our common stock trading at certain pre-determined prices. 416000 490000 16.72 62000 completion of service periods that ranged from 4 months to 1.3 years at inception and the achievement of our common stock trading at certain pre-determined prices. 182000 3.16 5000 <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_pn3n3_z9rjZ6Bjzka6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span id="xdx_8B8_zbTaccVMbsxc" style="display: none">Schedule of summary of stock option activity</span><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weighted-Average <br/>Exercise Price</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Number of Shares</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weighted-Average <br/>Exercise Price</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%">Outstanding at July 1,</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zj3qDs0TFaNc" title="Outstanding at beginning of period">267,750</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zrsQVA6Wrkd4" title="Outstanding at beginning of period (in dollars per share)">42.11</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zgftS81Nlryc" title="Outstanding at beginning of period">298,937</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z1OjgfIdHTO5" title="Outstanding at beginning of period (in dollars per share)">42.19</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zVYjM4bsGrXb" title="Options granted"><span style="-sec-ix-hidden: xdx2ixbrl1288">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zVi0S7qvyP39" title="Options granted (in dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1290">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zTlULHetITwh" title="Options granted"><span style="-sec-ix-hidden: xdx2ixbrl1292">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z2RQTDwjPwml" title="Options granted (in dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1294">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Options exercised </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zp2t8UCwVVce" title="Options exercised">(4,250</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z3Voz7eEHDU2" title="Options exercised (in dollars per share)">27.50</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zO4f8EkVrBy8" title="Options exercised"><span style="-sec-ix-hidden: xdx2ixbrl1300">—</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zdlA83gyhzZj" title="Options exercised (in dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1302">—</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Options forfeited/expired </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zbJAZoc6BeC5" title="Options forfeited">(26,250</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zptbJUFg0rFi" title="Options forfeited (in dollars per share)">42.00</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z4sJ93415rx2" title="Options forfeited">(31,187</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zgl1gw2QhwP1" title="Options forfeited (in dollars per share)">42.88</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30 </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_z5RegXmOvRgh" title="Outstanding at end of period">237,250</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240701__20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zkreVAFBMfE4" title="Outstanding at end of period (in dollars per share)">42.38</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zUROQtW39pRk" title="Outstanding at end of period">267,750</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230701__20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zcTb4MMec7Id" title="Outstanding at end of period (in dollars per share)">42.11</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Stock Options Exercisable at June 30,</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_pid_c20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zTUF963qxI3l" title="Stock Options Exercisable at end of period">79,750</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_pid_c20250630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zbq34jQUhyma" title="Stock Options Exercisable at end of period (in dollars per share)">32.27</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_pid_c20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zxCNPfwv2N76" title="Stock Options Exercisable at end of period">57,750</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_pid_c20240630__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionMember_zYCwrbRJV505" title="Stock Options Exercisable at end of period (in dollars per share)">27.50</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 267750 42.11 298937 42.19 4250 27.50 26250 42.00 31187 42.88 237250 42.38 267750 42.11 79750 32.27 57750 27.50 82000 299000 907000 0 0 18000 The shares vest ratably over five years from the date of grant. 857000 105000 753000 P53M offering and purchase periods of six months, and bases the pricing to purchase shares of our common stock on a formula so as to result in a per share purchase price that approximates a 15% discount from the market price of a share of our common stock at the end of the purchase period. 704715 1593 3004 26.42 16.64 37095 7000 9000 <p id="xdx_80A_eus-gaap--ConcentrationRiskDisclosureTextBlock_z9ebyPxRcYre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>12.        <span id="xdx_829_zFFWZFIrtZj5">MAJOR CUSTOMERS &amp; SUPPLIERS</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">Customers</span> that <span style="letter-spacing: 0pt">accounted for more than 10% of our total sales </span>in <span style="letter-spacing: 0pt">either of</span> fiscal year <span style="letter-spacing: 0pt">2025 or 2024, is as follows (in thousands, except percentages):</span></p> <p style="font: 10pt/10.5pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.7pt; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_pn3n3_zKhHoguLVJp8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - MAJOR CUSTOMERS &amp; SUPPLIERS (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8BB_zRD4WpRt7lWj" style="display: none">Schedule of sales by major customers</span></span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Percent of Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Percent of Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="14" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">Net sales </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_901_eus-gaap--Revenues_pn3n3_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zImYjTMq0MSl" title="Total revenue">66,593</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_900_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_z60EhtXa3Zwf" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90C_eus-gaap--Revenues_pn3n3_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zWCPi9blacTi" title="Total revenue">53,844</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90D_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zzSv67FOQ4of" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer concentration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 0.3in">Customer 1</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_eus-gaap--Revenues_pn3n3_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_z6JCFJub87Y2" title="Total revenue">49,930</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zBckDscyqvpi" title="Percentage of concentrations risk">75</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_eus-gaap--Revenues_pn3n3_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zB9me7JWBv29" title="Total revenue">38,159</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zSXwkwygzH01" title="Percentage of concentrations risk">71</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -10pt; padding-left: 0.3in">Customer 2</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--Revenues_pn3n3_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_zrjqHp9GTl7e" title="Total revenue">8,271</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_zTm0hR5KCIkl" title="Percentage of concentrations risk">12</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--Revenues_pn3n3_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_ziymblMfY2Vd" title="Total revenue">6,502</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_z4AnAsn42Uyd" title="Percentage of concentrations risk">12</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 0.3in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--Revenues_pn3n3_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zQVfxOymXtXf" title="Total revenue">58,201</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zn7fp8Fp3hj9" title="Percentage of concentrations risk">87</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zDNQn4GE5i3j" title="Total revenue">44,661</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zPobEj5VA039" title="Percentage of concentrations risk">83</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8AD_zYNXH8XgWSQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information with respect to accounts receivable from those customers who comprised more than 10% of our gross accounts receivable at either June 30, 2025 or June 30, 2024 is as follows (in thousands, except percentages):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_pn3n3_ztEzGWn48MQb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - MAJOR CUSTOMERS &amp; SUPPLIERS (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8B2_zwt9Na6XI65b" style="display: none">Schedule of accounts receivable, inventory purchases and accounts payable of major customers and suppliers</span></span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">Total gross accounts receivable </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_908_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zty7WUkdcPf4" title="Total gross accounts receivable">16,433</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zFupR7Omi6fi" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_902_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zRO4xUwQx7Oj" title="Total gross accounts receivable">13,887</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_907_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zhG77DZQUQvh" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.3in; padding-left: 0.3in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer concentration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0.15in">Customer 1</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zT1GvciSoa3d" title="Total gross accounts receivable">11,895</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zou7XquOVZLa" title="Percentage of concentrations risk">72</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zEAgSB7cGTy8" title="Total gross accounts receivable">10,488</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zKSrjEAza1Ti" title="Percentage of concentrations risk">76</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: 0pt; padding-left: 0.15in">Customer 2</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_z8ZtFPon9n8" title="Total gross accounts receivable">2,768</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_znIkqUZYE8Ed" title="Percentage of concentrations risk">17</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_z6EtYJQeIuk9" title="Total gross accounts receivable">2,423</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_zAkp2mlwwcub" title="Percentage of concentrations risk">17</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: 0pt; padding-left: 0.15in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zpYABxB2Fhy3" title="Total gross accounts receivable">14,663</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zqAuQLhkITS" title="Percentage of concentrations risk">89</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zWt3dxLHSLXa" title="Total gross accounts receivable">12,911</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zIKTY8RwlJJj" title="Percentage of concentrations risk">93</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During fiscal 2025 and 2024, we had three suppliers that accounted for more than 10% of total inventory purchases, as follows (in thousands, except percentages):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">Total inventory purchases </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_905_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zvwTSbTOk67f" title="Total inventory purchases">32,556</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_908_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zZg9SkwCGqd5" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_901_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zcWJns6I4RFh" title="Total inventory purchases">20,926</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_904_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zTfwVUn3OFed" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.3in; padding-left: 0.3in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier concentration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0.15in">Supplier 1</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zlhZSDaKSIj8" title="Total inventory purchases">7,018</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zmsibzjmwBjg" title="Percentage of concentrations risk">22</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zXOC4DwajaQh" title="Total inventory purchases">5,004</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zjAlDfw26NN9" title="Percentage of concentrations risk">24</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 0pt; padding-left: 0.15in">Supplier 2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_ztSAlx4kNgcj" title="Total inventory purchases">4,554</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zwDS20AVkfkj" title="Percentage of concentrations risk">14</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zNJk5ZZvpvC9" title="Total inventory purchases">2,401</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zLb8f8bT9GY2" title="Percentage of concentrations risk">11</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: 0pt; padding-left: 0.15in">Supplier 3</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_z0CFzBvcPDN" title="Total inventory purchases">4,192</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zvJBxIbGbVOi" title="Percentage of concentrations risk">13</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zfT8lQBkwhKg" title="Total inventory purchases">3,351</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zN7Lp8ZPevV7" title="Percentage of concentrations risk">16</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: 0pt; padding-left: 0.15in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zPAcFSz4335" title="Total inventory purchases">15,764</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_z3cPqtWN2iu4" title="Percentage of concentrations risk">49</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zVXuAu8yMVf1" title="Total inventory purchases">10,756</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zCVvhHAkc8ni" title="Percentage of concentrations risk">51</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information with respect to accounts payable due to our top three suppliers at June 30, 2025 or June 30, 2024 is as follows (in thousands, except percentages):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">Total accounts payable </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_907_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_ztO2FkuoGXRb" title="Total accounts payable">4,614</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zjyuiVius1ug" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_902_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zSHiaVs6t0ce" title="Total accounts payable">4,513</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_907_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zbyArho2z0E7" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.3in; padding-left: 0.3in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier concentration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0.15in">Supplier 1</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zcoa0SZ4Ifm7" title="Total accounts payable">735</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zJK8Cjsp2SWk" title="Percentage of concentrations risk">16</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zKzAKj2MGXSa" title="Total accounts payable">1,405</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zpJ2wlO11Hj9" title="Percentage of concentrations risk">31</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0.15in">Supplier 2 </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zVnYFyr6wzXf" title="Total accounts payable">1,016</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zcia2kgrGAxi" title="Percentage of concentrations risk">22</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_z2o8H6XuNncg" title="Total accounts payable">371</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zIoYKsbeNQ0d" title="Percentage of concentrations risk">8</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 0.15in">Supplier 3 </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zRL79Mf5swv4" title="Total accounts payable">298</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zO2Mz52YhRYc" title="Percentage of concentrations risk">6</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zPxlEevzx8u5" title="Total accounts payable">416</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zSCAxBGERrJ4" title="Percentage of concentrations risk">9</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: 0pt; padding-left: 0.15in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zc8euyc86Ca5" title="Total accounts payable">2,049</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zcgFIepVGjP1" title="Percentage of concentrations risk">44</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zaHOdb63NsA8" title="Total accounts payable">2,192</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zvTSn6ZWrvlh" title="Percentage of concentrations risk">48</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8AE_zagbxj8Kpbyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_pn3n3_zKhHoguLVJp8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - MAJOR CUSTOMERS &amp; SUPPLIERS (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8BB_zRD4WpRt7lWj" style="display: none">Schedule of sales by major customers</span></span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Percent of Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Percent of Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="14" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">Net sales </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_901_eus-gaap--Revenues_pn3n3_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zImYjTMq0MSl" title="Total revenue">66,593</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_900_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_z60EhtXa3Zwf" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90C_eus-gaap--Revenues_pn3n3_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zWCPi9blacTi" title="Total revenue">53,844</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90D_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zzSv67FOQ4of" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer concentration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 0.3in">Customer 1</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_908_eus-gaap--Revenues_pn3n3_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_z6JCFJub87Y2" title="Total revenue">49,930</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zBckDscyqvpi" title="Percentage of concentrations risk">75</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_eus-gaap--Revenues_pn3n3_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zB9me7JWBv29" title="Total revenue">38,159</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zSXwkwygzH01" title="Percentage of concentrations risk">71</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -10pt; padding-left: 0.3in">Customer 2</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--Revenues_pn3n3_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_zrjqHp9GTl7e" title="Total revenue">8,271</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_zTm0hR5KCIkl" title="Percentage of concentrations risk">12</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--Revenues_pn3n3_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_ziymblMfY2Vd" title="Total revenue">6,502</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_z4AnAsn42Uyd" title="Percentage of concentrations risk">12</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 0.3in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--Revenues_pn3n3_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zQVfxOymXtXf" title="Total revenue">58,201</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zn7fp8Fp3hj9" title="Percentage of concentrations risk">87</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--Revenues_pn3n3_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zDNQn4GE5i3j" title="Total revenue">44,661</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zPobEj5VA039" title="Percentage of concentrations risk">83</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 66593000 1 53844000 1 49930000 0.75 38159000 0.71 8271000 0.12 6502000 0.12 58201000 0.87 44661000 0.83 <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_pn3n3_ztEzGWn48MQb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - MAJOR CUSTOMERS &amp; SUPPLIERS (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> <span id="xdx_8B2_zwt9Na6XI65b" style="display: none">Schedule of accounts receivable, inventory purchases and accounts payable of major customers and suppliers</span></span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">Total gross accounts receivable </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_908_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zty7WUkdcPf4" title="Total gross accounts receivable">16,433</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zFupR7Omi6fi" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_902_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zRO4xUwQx7Oj" title="Total gross accounts receivable">13,887</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_907_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zhG77DZQUQvh" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.3in; padding-left: 0.3in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer concentration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0.15in">Customer 1</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zT1GvciSoa3d" title="Total gross accounts receivable">11,895</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zou7XquOVZLa" title="Percentage of concentrations risk">72</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_907_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zEAgSB7cGTy8" title="Total gross accounts receivable">10,488</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer1Member_zKSrjEAza1Ti" title="Percentage of concentrations risk">76</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: 0pt; padding-left: 0.15in">Customer 2</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_z8ZtFPon9n8" title="Total gross accounts receivable">2,768</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_znIkqUZYE8Ed" title="Percentage of concentrations risk">17</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_z6EtYJQeIuk9" title="Total gross accounts receivable">2,423</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--Customer2Member_zAkp2mlwwcub" title="Percentage of concentrations risk">17</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: 0pt; padding-left: 0.15in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zpYABxB2Fhy3" title="Total gross accounts receivable">14,663</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zqAuQLhkITS" title="Percentage of concentrations risk">89</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--AccountsReceivableGrossCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zWt3dxLHSLXa" title="Total gross accounts receivable">12,911</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalCustomerMember_zIKTY8RwlJJj" title="Percentage of concentrations risk">93</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During fiscal 2025 and 2024, we had three suppliers that accounted for more than 10% of total inventory purchases, as follows (in thousands, except percentages):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">Total inventory purchases </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_905_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zvwTSbTOk67f" title="Total inventory purchases">32,556</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_908_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zZg9SkwCGqd5" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_901_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zcWJns6I4RFh" title="Total inventory purchases">20,926</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_904_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zTfwVUn3OFed" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.3in; padding-left: 0.3in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier concentration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0.15in">Supplier 1</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zlhZSDaKSIj8" title="Total inventory purchases">7,018</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zmsibzjmwBjg" title="Percentage of concentrations risk">22</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zXOC4DwajaQh" title="Total inventory purchases">5,004</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zjAlDfw26NN9" title="Percentage of concentrations risk">24</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 0pt; padding-left: 0.15in">Supplier 2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_ztSAlx4kNgcj" title="Total inventory purchases">4,554</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zwDS20AVkfkj" title="Percentage of concentrations risk">14</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zNJk5ZZvpvC9" title="Total inventory purchases">2,401</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zLb8f8bT9GY2" title="Percentage of concentrations risk">11</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: 0pt; padding-left: 0.15in">Supplier 3</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_z0CFzBvcPDN" title="Total inventory purchases">4,192</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zvJBxIbGbVOi" title="Percentage of concentrations risk">13</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zfT8lQBkwhKg" title="Total inventory purchases">3,351</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zN7Lp8ZPevV7" title="Percentage of concentrations risk">16</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: 0pt; padding-left: 0.15in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zPAcFSz4335" title="Total inventory purchases">15,764</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_z3cPqtWN2iu4" title="Percentage of concentrations risk">49</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zVXuAu8yMVf1" title="Total inventory purchases">10,756</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--InventoryPurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zCVvhHAkc8ni" title="Percentage of concentrations risk">51</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information with respect to accounts payable due to our top three suppliers at June 30, 2025 or June 30, 2024 is as follows (in thousands, except percentages):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td colspan="2" style="text-align: right"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">June 30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">Total accounts payable </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_907_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_ztO2FkuoGXRb" title="Total accounts payable">4,614</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zjyuiVius1ug" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_902_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zSHiaVs6t0ce" title="Total accounts payable">4,513</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><span id="xdx_907_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zbyArho2z0E7" title="Percentage of concentrations risk">100</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.3in; padding-left: 0.3in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier concentration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0.15in">Supplier 1</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zcoa0SZ4Ifm7" title="Total accounts payable">735</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zJK8Cjsp2SWk" title="Percentage of concentrations risk">16</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zKzAKj2MGXSa" title="Total accounts payable">1,405</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier1Member_zpJ2wlO11Hj9" title="Percentage of concentrations risk">31</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0.15in">Supplier 2 </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zVnYFyr6wzXf" title="Total accounts payable">1,016</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zcia2kgrGAxi" title="Percentage of concentrations risk">22</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_z2o8H6XuNncg" title="Total accounts payable">371</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier2Member_zIoYKsbeNQ0d" title="Percentage of concentrations risk">8</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 0pt; padding-left: 0.15in">Supplier 3 </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zRL79Mf5swv4" title="Total accounts payable">298</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zO2Mz52YhRYc" title="Percentage of concentrations risk">6</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zPxlEevzx8u5" title="Total accounts payable">416</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--Supplier3Member_zSCAxBGERrJ4" title="Percentage of concentrations risk">9</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: 0pt; padding-left: 0.15in">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zc8euyc86Ca5" title="Total accounts payable">2,049</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zcgFIepVGjP1" title="Percentage of concentrations risk">44</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--AccountsPayableCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zaHOdb63NsA8" title="Total accounts payable">2,192</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_ecustom--PercentageOfConcentrationsRisk_pid_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TotalSupplierMember_zvTSn6ZWrvlh" title="Percentage of concentrations risk">48</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 16433000 1 13887000 1 11895000 0.72 10488000 0.76 2768000 0.17 2423000 0.17 14663000 0.89 12911000 0.93 32556000 1 20926000 1 7018000 0.22 5004000 0.24 4554000 0.14 2401000 0.11 4192000 0.13 3351000 0.16 15764000 0.49 10756000 0.51 4614000 1 4513000 1 735000 0.16 1405000 0.31 1016000 0.22 371000 0.08 298000 0.06 416000 0.09 2049000 0.44 2192000 0.48 <p id="xdx_800_eus-gaap--EarningsPerShareTextBlock_zFmRtmfuFO9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>13.</b>        <b><span id="xdx_824_ztl04mzOiknj">NET INCOME PER SHARE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We calculate basic earnings per share by dividing net income by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share reflects the effects of potentially dilutive securities based upon the treasury stock method for in-the-money stock options and the fully diluted shares outstanding method for restricted stock and performance awards. The summary of the basic and diluted earnings per share calculations for the years ended June 30, 2025 and 2024 is as follows (in thousands, except per share data):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_z2mQGWmLPIQ8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NET INCOME PER SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-indent: -0.25in; padding-left: 0.25in"><span style="font-size: 8pt"> <span id="xdx_8B7_zgH35RdOfQXb" style="display: none">Schedule of net income per share</span></span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td id="xdx_49E_20240701__20250630_zK2UlnoymSZ8" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td id="xdx_499_20230701__20240630_z6093KEf95ck" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareBasicAbstract_iB_zQL7Fv5OrLP9" style="vertical-align: bottom"> <td style="font-weight: bold">Basic:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--NetIncomeLoss_i01_pn3n3_ztDjU7TEh84" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Net income </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">8,978</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,127</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--WeightedaverageShareOutstanding_i01_pid_zsOZAMb9ohId" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in">Weighted-average shares outstanding </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,288</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,499</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_i01_pid_zZZMYaPOYnek" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in">Basic earnings per share </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.61</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--EarningsPerShareDilutedAbstract_iB_z5VTdjmgJTH4" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-indent: -0.25in; padding-left: 0.25in">Diluted:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLoss_i01_pn3n3_z0cSeBAcG6rj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.25in; padding-left: 0.25in">Net income </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,978</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,127</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--WeightedaverageSharesOutstanding_i01_pid_zMbaKpvG9aZ1" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.25in; padding-left: 0.25in">Weighted-average shares outstanding </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,288</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,499</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pid_zsZyjnSCW896" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in">Effect of dilutive securities – stock options &amp; performance awards </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">73</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">72</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--WeightedaverageSharesUsedInCalculationOfDilutedEarningsPerShare_i01_pid_zL5VwPe31Jl2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in">Weighted-average shares used in calculation of diluted earnings per share </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,361</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,571</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_i01_pid_zn7Pl8jC5157" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in">Diluted earnings per share </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.67</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.60</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_z2mQGWmLPIQ8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NET INCOME PER SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-indent: -0.25in; padding-left: 0.25in"><span style="font-size: 8pt"> <span id="xdx_8B7_zgH35RdOfQXb" style="display: none">Schedule of net income per share</span></span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td id="xdx_49E_20240701__20250630_zK2UlnoymSZ8" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td><td><span style="font-size: 8pt"> </span></td> <td style="text-align: left"><span style="font-size: 8pt"> </span></td><td id="xdx_499_20230701__20240630_z6093KEf95ck" style="text-align: right"><span style="font-size: 8pt"> </span></td><td style="text-align: left"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Years Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2025</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareBasicAbstract_iB_zQL7Fv5OrLP9" style="vertical-align: bottom"> <td style="font-weight: bold">Basic:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--NetIncomeLoss_i01_pn3n3_ztDjU7TEh84" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Net income </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">8,978</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,127</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--WeightedaverageShareOutstanding_i01_pid_zsOZAMb9ohId" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in">Weighted-average shares outstanding </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,288</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,499</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_i01_pid_zZZMYaPOYnek" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in">Basic earnings per share </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.61</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--EarningsPerShareDilutedAbstract_iB_z5VTdjmgJTH4" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-indent: -0.25in; padding-left: 0.25in">Diluted:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLoss_i01_pn3n3_z0cSeBAcG6rj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.25in; padding-left: 0.25in">Net income </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,978</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,127</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--WeightedaverageSharesOutstanding_i01_pid_zMbaKpvG9aZ1" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.25in; padding-left: 0.25in">Weighted-average shares outstanding </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,288</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,499</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pid_zsZyjnSCW896" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in">Effect of dilutive securities – stock options &amp; performance awards </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">73</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">72</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--WeightedaverageSharesUsedInCalculationOfDilutedEarningsPerShare_i01_pid_zL5VwPe31Jl2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in">Weighted-average shares used in calculation of diluted earnings per share </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,361</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,571</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_i01_pid_zn7Pl8jC5157" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in">Diluted earnings per share </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.67</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.60</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 8978000 2127000 3288 3499 2.73 0.61 8978000 2127000 3288 3499 73 72 3361 3571 2.67 0.60 <p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zuENwRSfGxD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>14.        <span id="xdx_828_zaLlzDVHwmbg">COMMON STOCK – Share Repurchase Program</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt"><span style="font-family: inherit,serif"><b> </b></span>In December 2019, our Board approved a new share repurchase program authorizing us to repurchase up to one million shares of our common stock, as the prior repurchase plan authorized by our Board in 2013 was nearing completion. In accordance with, and as part of, these shares repurchase programs, our Board approved the adoption of several prearranged share repurchase plans intended to qualify for the safe harbor provided by Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (“10b5-1 Plan” or “Plan”). During the fiscal year ended June 30, 2025, we repurchased <span id="xdx_90E_eus-gaap--StockRepurchasedDuringPeriodShares_c20240701__20250630__us-gaap--PlanNameAxis__custom--Tenb51PlanMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember_pd" title="Repurchased shares">130,148</span> shares at an aggregate cost, inclusive of fees under the Plan, of $<span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodValue_pn5n6_c20240701__20250630__us-gaap--PlanNameAxis__custom--Tenb51PlanMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember_z7M24AWyYLj5" title="Aggregate cost">3.5</span> million. During the fiscal year ended June 30, 2024, we repurchased <span id="xdx_90C_eus-gaap--StockRepurchasedDuringPeriodShares_c20230701__20240630__us-gaap--PlanNameAxis__custom--Tenb51PlanMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember_pd" title="Repurchased shares">184,901</span> shares at an aggregate cost, inclusive of fees under the Plan, of $<span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodValue_pn5n6_c20230701__20240630__us-gaap--PlanNameAxis__custom--Tenb51PlanMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember_zxENqIXXXNTg" title="Aggregate cost">3.5</span> million. On a cumulative basis, since 2013 we have repurchased a total of <span id="xdx_900_eus-gaap--StockRepurchasedDuringPeriodShares_c20191230__20191231__us-gaap--PlanNameAxis__custom--Tenb51PlanMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember__us-gaap--StatementEquityComponentsAxis__custom--CumulativeBasisMember_pd" title="Repurchased shares">1,511,497</span> shares under the share repurchase programs at an aggregate cost, inclusive of fees under the Plan, of $<span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodValue_pn5n6_c20191230__20191231__us-gaap--PlanNameAxis__custom--Tenb51PlanMember__srt--ShareRepurchaseProgramAxis__custom--ShareRepurchaseProgramMember__us-gaap--StatementEquityComponentsAxis__custom--CumulativeBasisMember_zTuviOFxWO4a" title="Aggregate cost">24.2</span> million. All repurchases under the 10b5-1 Plans were administered through an independent broker.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt"> </p> 130148 3500000 184901 3500000 1511497 24200000 <p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zddO6Rz0V8wd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>15.        <span id="xdx_827_zHDdvauRjGkj">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><b> </b>We have evaluated subsequent events through the date of this filing. There were no subsequent events that require disclosure.</p> false false false false true